context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
The Company recorded a net $ 7 decrease, $ 2 decrease, and $ 1 decrease to U.S. state valuation allowances in 2024, 2023, and 2022, respectively. After weighing all available positive and negative evidence, the Company determined the adjustments based on the underlying net deferred tax assets that were more likely than not realizable based on projected taxable income. Changes in fully reserved U.S. state tax losses, credits and other deferred tax assets resulting from expirations, audit adjustments, tax rate, and tax law changes also resulted in a corresponding net $ 30 decrease, $ 49 decrease, and $ 142 decrease in the valuation allowance in 2024, 2023, and 2022, respectively. Valuation allowances of $ 401 remain against state deferred tax assets expected to expire before utilization. The need for valuation allowances against state deferred tax assets will be reassessed on a continuous basis in future periods and, as a result, the allowance may increase or decrease based on changes in facts and circumstances. | text | 2 | monetaryItemType | text: <entity> 2 </entity> <entity type> monetaryItemType </entity type> <context> The Company recorded a net $ 7 decrease, $ 2 decrease, and $ 1 decrease to U.S. state valuation allowances in 2024, 2023, and 2022, respectively. After weighing all available positive and negative evidence, the Company determined the adjustments based on the underlying net deferred tax assets that were more likely than not realizable based on projected taxable income. Changes in fully reserved U.S. state tax losses, credits and other deferred tax assets resulting from expirations, audit adjustments, tax rate, and tax law changes also resulted in a corresponding net $ 30 decrease, $ 49 decrease, and $ 142 decrease in the valuation allowance in 2024, 2023, and 2022, respectively. Valuation allowances of $ 401 remain against state deferred tax assets expected to expire before utilization. The need for valuation allowances against state deferred tax assets will be reassessed on a continuous basis in future periods and, as a result, the allowance may increase or decrease based on changes in facts and circumstances. </context> | us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount |
The Company recorded a net $ 7 decrease, $ 2 decrease, and $ 1 decrease to U.S. state valuation allowances in 2024, 2023, and 2022, respectively. After weighing all available positive and negative evidence, the Company determined the adjustments based on the underlying net deferred tax assets that were more likely than not realizable based on projected taxable income. Changes in fully reserved U.S. state tax losses, credits and other deferred tax assets resulting from expirations, audit adjustments, tax rate, and tax law changes also resulted in a corresponding net $ 30 decrease, $ 49 decrease, and $ 142 decrease in the valuation allowance in 2024, 2023, and 2022, respectively. Valuation allowances of $ 401 remain against state deferred tax assets expected to expire before utilization. The need for valuation allowances against state deferred tax assets will be reassessed on a continuous basis in future periods and, as a result, the allowance may increase or decrease based on changes in facts and circumstances. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> The Company recorded a net $ 7 decrease, $ 2 decrease, and $ 1 decrease to U.S. state valuation allowances in 2024, 2023, and 2022, respectively. After weighing all available positive and negative evidence, the Company determined the adjustments based on the underlying net deferred tax assets that were more likely than not realizable based on projected taxable income. Changes in fully reserved U.S. state tax losses, credits and other deferred tax assets resulting from expirations, audit adjustments, tax rate, and tax law changes also resulted in a corresponding net $ 30 decrease, $ 49 decrease, and $ 142 decrease in the valuation allowance in 2024, 2023, and 2022, respectively. Valuation allowances of $ 401 remain against state deferred tax assets expected to expire before utilization. The need for valuation allowances against state deferred tax assets will be reassessed on a continuous basis in future periods and, as a result, the allowance may increase or decrease based on changes in facts and circumstances. </context> | us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount |
The Company recorded a net $ 7 decrease, $ 2 decrease, and $ 1 decrease to U.S. state valuation allowances in 2024, 2023, and 2022, respectively. After weighing all available positive and negative evidence, the Company determined the adjustments based on the underlying net deferred tax assets that were more likely than not realizable based on projected taxable income. Changes in fully reserved U.S. state tax losses, credits and other deferred tax assets resulting from expirations, audit adjustments, tax rate, and tax law changes also resulted in a corresponding net $ 30 decrease, $ 49 decrease, and $ 142 decrease in the valuation allowance in 2024, 2023, and 2022, respectively. Valuation allowances of $ 401 remain against state deferred tax assets expected to expire before utilization. The need for valuation allowances against state deferred tax assets will be reassessed on a continuous basis in future periods and, as a result, the allowance may increase or decrease based on changes in facts and circumstances. | text | 30 | monetaryItemType | text: <entity> 30 </entity> <entity type> monetaryItemType </entity type> <context> The Company recorded a net $ 7 decrease, $ 2 decrease, and $ 1 decrease to U.S. state valuation allowances in 2024, 2023, and 2022, respectively. After weighing all available positive and negative evidence, the Company determined the adjustments based on the underlying net deferred tax assets that were more likely than not realizable based on projected taxable income. Changes in fully reserved U.S. state tax losses, credits and other deferred tax assets resulting from expirations, audit adjustments, tax rate, and tax law changes also resulted in a corresponding net $ 30 decrease, $ 49 decrease, and $ 142 decrease in the valuation allowance in 2024, 2023, and 2022, respectively. Valuation allowances of $ 401 remain against state deferred tax assets expected to expire before utilization. The need for valuation allowances against state deferred tax assets will be reassessed on a continuous basis in future periods and, as a result, the allowance may increase or decrease based on changes in facts and circumstances. </context> | us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount |
The Company recorded a net $ 7 decrease, $ 2 decrease, and $ 1 decrease to U.S. state valuation allowances in 2024, 2023, and 2022, respectively. After weighing all available positive and negative evidence, the Company determined the adjustments based on the underlying net deferred tax assets that were more likely than not realizable based on projected taxable income. Changes in fully reserved U.S. state tax losses, credits and other deferred tax assets resulting from expirations, audit adjustments, tax rate, and tax law changes also resulted in a corresponding net $ 30 decrease, $ 49 decrease, and $ 142 decrease in the valuation allowance in 2024, 2023, and 2022, respectively. Valuation allowances of $ 401 remain against state deferred tax assets expected to expire before utilization. The need for valuation allowances against state deferred tax assets will be reassessed on a continuous basis in future periods and, as a result, the allowance may increase or decrease based on changes in facts and circumstances. | text | 49 | monetaryItemType | text: <entity> 49 </entity> <entity type> monetaryItemType </entity type> <context> The Company recorded a net $ 7 decrease, $ 2 decrease, and $ 1 decrease to U.S. state valuation allowances in 2024, 2023, and 2022, respectively. After weighing all available positive and negative evidence, the Company determined the adjustments based on the underlying net deferred tax assets that were more likely than not realizable based on projected taxable income. Changes in fully reserved U.S. state tax losses, credits and other deferred tax assets resulting from expirations, audit adjustments, tax rate, and tax law changes also resulted in a corresponding net $ 30 decrease, $ 49 decrease, and $ 142 decrease in the valuation allowance in 2024, 2023, and 2022, respectively. Valuation allowances of $ 401 remain against state deferred tax assets expected to expire before utilization. The need for valuation allowances against state deferred tax assets will be reassessed on a continuous basis in future periods and, as a result, the allowance may increase or decrease based on changes in facts and circumstances. </context> | us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount |
The Company recorded a net $ 7 decrease, $ 2 decrease, and $ 1 decrease to U.S. state valuation allowances in 2024, 2023, and 2022, respectively. After weighing all available positive and negative evidence, the Company determined the adjustments based on the underlying net deferred tax assets that were more likely than not realizable based on projected taxable income. Changes in fully reserved U.S. state tax losses, credits and other deferred tax assets resulting from expirations, audit adjustments, tax rate, and tax law changes also resulted in a corresponding net $ 30 decrease, $ 49 decrease, and $ 142 decrease in the valuation allowance in 2024, 2023, and 2022, respectively. Valuation allowances of $ 401 remain against state deferred tax assets expected to expire before utilization. The need for valuation allowances against state deferred tax assets will be reassessed on a continuous basis in future periods and, as a result, the allowance may increase or decrease based on changes in facts and circumstances. | text | 142 | monetaryItemType | text: <entity> 142 </entity> <entity type> monetaryItemType </entity type> <context> The Company recorded a net $ 7 decrease, $ 2 decrease, and $ 1 decrease to U.S. state valuation allowances in 2024, 2023, and 2022, respectively. After weighing all available positive and negative evidence, the Company determined the adjustments based on the underlying net deferred tax assets that were more likely than not realizable based on projected taxable income. Changes in fully reserved U.S. state tax losses, credits and other deferred tax assets resulting from expirations, audit adjustments, tax rate, and tax law changes also resulted in a corresponding net $ 30 decrease, $ 49 decrease, and $ 142 decrease in the valuation allowance in 2024, 2023, and 2022, respectively. Valuation allowances of $ 401 remain against state deferred tax assets expected to expire before utilization. The need for valuation allowances against state deferred tax assets will be reassessed on a continuous basis in future periods and, as a result, the allowance may increase or decrease based on changes in facts and circumstances. </context> | us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount |
The Company recorded a net $ 7 decrease, $ 2 decrease, and $ 1 decrease to U.S. state valuation allowances in 2024, 2023, and 2022, respectively. After weighing all available positive and negative evidence, the Company determined the adjustments based on the underlying net deferred tax assets that were more likely than not realizable based on projected taxable income. Changes in fully reserved U.S. state tax losses, credits and other deferred tax assets resulting from expirations, audit adjustments, tax rate, and tax law changes also resulted in a corresponding net $ 30 decrease, $ 49 decrease, and $ 142 decrease in the valuation allowance in 2024, 2023, and 2022, respectively. Valuation allowances of $ 401 remain against state deferred tax assets expected to expire before utilization. The need for valuation allowances against state deferred tax assets will be reassessed on a continuous basis in future periods and, as a result, the allowance may increase or decrease based on changes in facts and circumstances. | text | 401 | monetaryItemType | text: <entity> 401 </entity> <entity type> monetaryItemType </entity type> <context> The Company recorded a net $ 7 decrease, $ 2 decrease, and $ 1 decrease to U.S. state valuation allowances in 2024, 2023, and 2022, respectively. After weighing all available positive and negative evidence, the Company determined the adjustments based on the underlying net deferred tax assets that were more likely than not realizable based on projected taxable income. Changes in fully reserved U.S. state tax losses, credits and other deferred tax assets resulting from expirations, audit adjustments, tax rate, and tax law changes also resulted in a corresponding net $ 30 decrease, $ 49 decrease, and $ 142 decrease in the valuation allowance in 2024, 2023, and 2022, respectively. Valuation allowances of $ 401 remain against state deferred tax assets expected to expire before utilization. The need for valuation allowances against state deferred tax assets will be reassessed on a continuous basis in future periods and, as a result, the allowance may increase or decrease based on changes in facts and circumstances. </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
In 2022, after weighing all available evidence, the Company released a $ 6 valuation allowance in the U.K. related to interest deduction carryforwards. The need for valuation allowances will be reassessed by entity and by jurisdiction on a continuous basis in future periods and, as a result, the allowances may increase or decrease based on changes in facts and circumstances. | text | 6 | monetaryItemType | text: <entity> 6 </entity> <entity type> monetaryItemType </entity type> <context> In 2022, after weighing all available evidence, the Company released a $ 6 valuation allowance in the U.K. related to interest deduction carryforwards. The need for valuation allowances will be reassessed by entity and by jurisdiction on a continuous basis in future periods and, as a result, the allowances may increase or decrease based on changes in facts and circumstances. </context> | us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount |
Howmet and its subsidiaries file income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. With a few minor exceptions, Howmet is no longer subject to income tax examinations by tax authorities for years prior to 2014. All U.S. tax years prior to 2024 have been audited by the Internal Revenue Service. Various state and foreign jurisdiction tax authorities are in the process of examining the Company’s income tax returns for various tax years through 2023. The Company had net cash income tax payments of $ 177 , $ 104 , and $ 50 in 2024, 2023, and 2022, respectively. | text | 177 | monetaryItemType | text: <entity> 177 </entity> <entity type> monetaryItemType </entity type> <context> Howmet and its subsidiaries file income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. With a few minor exceptions, Howmet is no longer subject to income tax examinations by tax authorities for years prior to 2014. All U.S. tax years prior to 2024 have been audited by the Internal Revenue Service. Various state and foreign jurisdiction tax authorities are in the process of examining the Company’s income tax returns for various tax years through 2023. The Company had net cash income tax payments of $ 177 , $ 104 , and $ 50 in 2024, 2023, and 2022, respectively. </context> | us-gaap:IncomeTaxesPaidNet |
Howmet and its subsidiaries file income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. With a few minor exceptions, Howmet is no longer subject to income tax examinations by tax authorities for years prior to 2014. All U.S. tax years prior to 2024 have been audited by the Internal Revenue Service. Various state and foreign jurisdiction tax authorities are in the process of examining the Company’s income tax returns for various tax years through 2023. The Company had net cash income tax payments of $ 177 , $ 104 , and $ 50 in 2024, 2023, and 2022, respectively. | text | 104 | monetaryItemType | text: <entity> 104 </entity> <entity type> monetaryItemType </entity type> <context> Howmet and its subsidiaries file income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. With a few minor exceptions, Howmet is no longer subject to income tax examinations by tax authorities for years prior to 2014. All U.S. tax years prior to 2024 have been audited by the Internal Revenue Service. Various state and foreign jurisdiction tax authorities are in the process of examining the Company’s income tax returns for various tax years through 2023. The Company had net cash income tax payments of $ 177 , $ 104 , and $ 50 in 2024, 2023, and 2022, respectively. </context> | us-gaap:IncomeTaxesPaidNet |
Howmet and its subsidiaries file income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. With a few minor exceptions, Howmet is no longer subject to income tax examinations by tax authorities for years prior to 2014. All U.S. tax years prior to 2024 have been audited by the Internal Revenue Service. Various state and foreign jurisdiction tax authorities are in the process of examining the Company’s income tax returns for various tax years through 2023. The Company had net cash income tax payments of $ 177 , $ 104 , and $ 50 in 2024, 2023, and 2022, respectively. | text | 50 | monetaryItemType | text: <entity> 50 </entity> <entity type> monetaryItemType </entity type> <context> Howmet and its subsidiaries file income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. With a few minor exceptions, Howmet is no longer subject to income tax examinations by tax authorities for years prior to 2014. All U.S. tax years prior to 2024 have been audited by the Internal Revenue Service. Various state and foreign jurisdiction tax authorities are in the process of examining the Company’s income tax returns for various tax years through 2023. The Company had net cash income tax payments of $ 177 , $ 104 , and $ 50 in 2024, 2023, and 2022, respectively. </context> | us-gaap:IncomeTaxesPaidNet |
It is Howmet’s policy to recognize interest and penalties related to income taxes as a component of the Provision for income taxes in the Statement of Consolidated Operations. Howmet recognized interest and penalties of $ 1 , $ 7 , and less than $ 1 in 2024, 2023, and 2022, respectively. Due to the expiration of the statute of limitations, settlements with tax authorities, reductions in prior accruals, and refunded overpayments, Howmet recognized interest income of $ 0 , $ 2 , and less than $ 1 in 2024, 2023, and 2022, respectively. As of December 31, 2024, 2023, and 2022, the amount accrued for the payment of interest and penalties was $ 9 , $ 11 , and less than $ 1 , respectively. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> It is Howmet’s policy to recognize interest and penalties related to income taxes as a component of the Provision for income taxes in the Statement of Consolidated Operations. Howmet recognized interest and penalties of $ 1 , $ 7 , and less than $ 1 in 2024, 2023, and 2022, respectively. Due to the expiration of the statute of limitations, settlements with tax authorities, reductions in prior accruals, and refunded overpayments, Howmet recognized interest income of $ 0 , $ 2 , and less than $ 1 in 2024, 2023, and 2022, respectively. As of December 31, 2024, 2023, and 2022, the amount accrued for the payment of interest and penalties was $ 9 , $ 11 , and less than $ 1 , respectively. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense |
It is Howmet’s policy to recognize interest and penalties related to income taxes as a component of the Provision for income taxes in the Statement of Consolidated Operations. Howmet recognized interest and penalties of $ 1 , $ 7 , and less than $ 1 in 2024, 2023, and 2022, respectively. Due to the expiration of the statute of limitations, settlements with tax authorities, reductions in prior accruals, and refunded overpayments, Howmet recognized interest income of $ 0 , $ 2 , and less than $ 1 in 2024, 2023, and 2022, respectively. As of December 31, 2024, 2023, and 2022, the amount accrued for the payment of interest and penalties was $ 9 , $ 11 , and less than $ 1 , respectively. | text | 7 | monetaryItemType | text: <entity> 7 </entity> <entity type> monetaryItemType </entity type> <context> It is Howmet’s policy to recognize interest and penalties related to income taxes as a component of the Provision for income taxes in the Statement of Consolidated Operations. Howmet recognized interest and penalties of $ 1 , $ 7 , and less than $ 1 in 2024, 2023, and 2022, respectively. Due to the expiration of the statute of limitations, settlements with tax authorities, reductions in prior accruals, and refunded overpayments, Howmet recognized interest income of $ 0 , $ 2 , and less than $ 1 in 2024, 2023, and 2022, respectively. As of December 31, 2024, 2023, and 2022, the amount accrued for the payment of interest and penalties was $ 9 , $ 11 , and less than $ 1 , respectively. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense |
It is Howmet’s policy to recognize interest and penalties related to income taxes as a component of the Provision for income taxes in the Statement of Consolidated Operations. Howmet recognized interest and penalties of $ 1 , $ 7 , and less than $ 1 in 2024, 2023, and 2022, respectively. Due to the expiration of the statute of limitations, settlements with tax authorities, reductions in prior accruals, and refunded overpayments, Howmet recognized interest income of $ 0 , $ 2 , and less than $ 1 in 2024, 2023, and 2022, respectively. As of December 31, 2024, 2023, and 2022, the amount accrued for the payment of interest and penalties was $ 9 , $ 11 , and less than $ 1 , respectively. | text | 9 | monetaryItemType | text: <entity> 9 </entity> <entity type> monetaryItemType </entity type> <context> It is Howmet’s policy to recognize interest and penalties related to income taxes as a component of the Provision for income taxes in the Statement of Consolidated Operations. Howmet recognized interest and penalties of $ 1 , $ 7 , and less than $ 1 in 2024, 2023, and 2022, respectively. Due to the expiration of the statute of limitations, settlements with tax authorities, reductions in prior accruals, and refunded overpayments, Howmet recognized interest income of $ 0 , $ 2 , and less than $ 1 in 2024, 2023, and 2022, respectively. As of December 31, 2024, 2023, and 2022, the amount accrued for the payment of interest and penalties was $ 9 , $ 11 , and less than $ 1 , respectively. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued |
It is Howmet’s policy to recognize interest and penalties related to income taxes as a component of the Provision for income taxes in the Statement of Consolidated Operations. Howmet recognized interest and penalties of $ 1 , $ 7 , and less than $ 1 in 2024, 2023, and 2022, respectively. Due to the expiration of the statute of limitations, settlements with tax authorities, reductions in prior accruals, and refunded overpayments, Howmet recognized interest income of $ 0 , $ 2 , and less than $ 1 in 2024, 2023, and 2022, respectively. As of December 31, 2024, 2023, and 2022, the amount accrued for the payment of interest and penalties was $ 9 , $ 11 , and less than $ 1 , respectively. | text | 11 | monetaryItemType | text: <entity> 11 </entity> <entity type> monetaryItemType </entity type> <context> It is Howmet’s policy to recognize interest and penalties related to income taxes as a component of the Provision for income taxes in the Statement of Consolidated Operations. Howmet recognized interest and penalties of $ 1 , $ 7 , and less than $ 1 in 2024, 2023, and 2022, respectively. Due to the expiration of the statute of limitations, settlements with tax authorities, reductions in prior accruals, and refunded overpayments, Howmet recognized interest income of $ 0 , $ 2 , and less than $ 1 in 2024, 2023, and 2022, respectively. As of December 31, 2024, 2023, and 2022, the amount accrued for the payment of interest and penalties was $ 9 , $ 11 , and less than $ 1 , respectively. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued |
It is Howmet’s policy to recognize interest and penalties related to income taxes as a component of the Provision for income taxes in the Statement of Consolidated Operations. Howmet recognized interest and penalties of $ 1 , $ 7 , and less than $ 1 in 2024, 2023, and 2022, respectively. Due to the expiration of the statute of limitations, settlements with tax authorities, reductions in prior accruals, and refunded overpayments, Howmet recognized interest income of $ 0 , $ 2 , and less than $ 1 in 2024, 2023, and 2022, respectively. As of December 31, 2024, 2023, and 2022, the amount accrued for the payment of interest and penalties was $ 9 , $ 11 , and less than $ 1 , respectively. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> It is Howmet’s policy to recognize interest and penalties related to income taxes as a component of the Provision for income taxes in the Statement of Consolidated Operations. Howmet recognized interest and penalties of $ 1 , $ 7 , and less than $ 1 in 2024, 2023, and 2022, respectively. Due to the expiration of the statute of limitations, settlements with tax authorities, reductions in prior accruals, and refunded overpayments, Howmet recognized interest income of $ 0 , $ 2 , and less than $ 1 in 2024, 2023, and 2022, respectively. As of December 31, 2024, 2023, and 2022, the amount accrued for the payment of interest and penalties was $ 9 , $ 11 , and less than $ 1 , respectively. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued |
Howmet has two classes of preferred stock: $ 3.75 Cumulative Preferred Stock (“Class A Preferred Stock”) and Class B Serial Preferred Stock. Class A Preferred Stock has 660,000 shares authorized at a par value of $ 100 per share with an annual $ 3.75 cumulative dividend preference per share. There were 546,024 shares of Class A Preferred Stock outstanding as of both December 31, 2024 and 2023. Class B Serial Preferred Stock has 10,000,000 shares authorized at a par value of $ 1 per share. There were no shares of Class B Serial Preferred Stock outstanding as of both December 31, 2024 and 2023. | text | 3.75 | perShareItemType | text: <entity> 3.75 </entity> <entity type> perShareItemType </entity type> <context> Howmet has two classes of preferred stock: $ 3.75 Cumulative Preferred Stock (“Class A Preferred Stock”) and Class B Serial Preferred Stock. Class A Preferred Stock has 660,000 shares authorized at a par value of $ 100 per share with an annual $ 3.75 cumulative dividend preference per share. There were 546,024 shares of Class A Preferred Stock outstanding as of both December 31, 2024 and 2023. Class B Serial Preferred Stock has 10,000,000 shares authorized at a par value of $ 1 per share. There were no shares of Class B Serial Preferred Stock outstanding as of both December 31, 2024 and 2023. </context> | us-gaap:PreferredStockDividendsPerShareDeclared |
Howmet has two classes of preferred stock: $ 3.75 Cumulative Preferred Stock (“Class A Preferred Stock”) and Class B Serial Preferred Stock. Class A Preferred Stock has 660,000 shares authorized at a par value of $ 100 per share with an annual $ 3.75 cumulative dividend preference per share. There were 546,024 shares of Class A Preferred Stock outstanding as of both December 31, 2024 and 2023. Class B Serial Preferred Stock has 10,000,000 shares authorized at a par value of $ 1 per share. There were no shares of Class B Serial Preferred Stock outstanding as of both December 31, 2024 and 2023. | text | 660000 | sharesItemType | text: <entity> 660000 </entity> <entity type> sharesItemType </entity type> <context> Howmet has two classes of preferred stock: $ 3.75 Cumulative Preferred Stock (“Class A Preferred Stock”) and Class B Serial Preferred Stock. Class A Preferred Stock has 660,000 shares authorized at a par value of $ 100 per share with an annual $ 3.75 cumulative dividend preference per share. There were 546,024 shares of Class A Preferred Stock outstanding as of both December 31, 2024 and 2023. Class B Serial Preferred Stock has 10,000,000 shares authorized at a par value of $ 1 per share. There were no shares of Class B Serial Preferred Stock outstanding as of both December 31, 2024 and 2023. </context> | us-gaap:PreferredStockSharesAuthorized |
Howmet has two classes of preferred stock: $ 3.75 Cumulative Preferred Stock (“Class A Preferred Stock”) and Class B Serial Preferred Stock. Class A Preferred Stock has 660,000 shares authorized at a par value of $ 100 per share with an annual $ 3.75 cumulative dividend preference per share. There were 546,024 shares of Class A Preferred Stock outstanding as of both December 31, 2024 and 2023. Class B Serial Preferred Stock has 10,000,000 shares authorized at a par value of $ 1 per share. There were no shares of Class B Serial Preferred Stock outstanding as of both December 31, 2024 and 2023. | text | 100 | perShareItemType | text: <entity> 100 </entity> <entity type> perShareItemType </entity type> <context> Howmet has two classes of preferred stock: $ 3.75 Cumulative Preferred Stock (“Class A Preferred Stock”) and Class B Serial Preferred Stock. Class A Preferred Stock has 660,000 shares authorized at a par value of $ 100 per share with an annual $ 3.75 cumulative dividend preference per share. There were 546,024 shares of Class A Preferred Stock outstanding as of both December 31, 2024 and 2023. Class B Serial Preferred Stock has 10,000,000 shares authorized at a par value of $ 1 per share. There were no shares of Class B Serial Preferred Stock outstanding as of both December 31, 2024 and 2023. </context> | us-gaap:PreferredStockParOrStatedValuePerShare |
Howmet has two classes of preferred stock: $ 3.75 Cumulative Preferred Stock (“Class A Preferred Stock”) and Class B Serial Preferred Stock. Class A Preferred Stock has 660,000 shares authorized at a par value of $ 100 per share with an annual $ 3.75 cumulative dividend preference per share. There were 546,024 shares of Class A Preferred Stock outstanding as of both December 31, 2024 and 2023. Class B Serial Preferred Stock has 10,000,000 shares authorized at a par value of $ 1 per share. There were no shares of Class B Serial Preferred Stock outstanding as of both December 31, 2024 and 2023. | text | 10000000 | sharesItemType | text: <entity> 10000000 </entity> <entity type> sharesItemType </entity type> <context> Howmet has two classes of preferred stock: $ 3.75 Cumulative Preferred Stock (“Class A Preferred Stock”) and Class B Serial Preferred Stock. Class A Preferred Stock has 660,000 shares authorized at a par value of $ 100 per share with an annual $ 3.75 cumulative dividend preference per share. There were 546,024 shares of Class A Preferred Stock outstanding as of both December 31, 2024 and 2023. Class B Serial Preferred Stock has 10,000,000 shares authorized at a par value of $ 1 per share. There were no shares of Class B Serial Preferred Stock outstanding as of both December 31, 2024 and 2023. </context> | us-gaap:PreferredStockSharesAuthorized |
Howmet has two classes of preferred stock: $ 3.75 Cumulative Preferred Stock (“Class A Preferred Stock”) and Class B Serial Preferred Stock. Class A Preferred Stock has 660,000 shares authorized at a par value of $ 100 per share with an annual $ 3.75 cumulative dividend preference per share. There were 546,024 shares of Class A Preferred Stock outstanding as of both December 31, 2024 and 2023. Class B Serial Preferred Stock has 10,000,000 shares authorized at a par value of $ 1 per share. There were no shares of Class B Serial Preferred Stock outstanding as of both December 31, 2024 and 2023. | text | 1 | perShareItemType | text: <entity> 1 </entity> <entity type> perShareItemType </entity type> <context> Howmet has two classes of preferred stock: $ 3.75 Cumulative Preferred Stock (“Class A Preferred Stock”) and Class B Serial Preferred Stock. Class A Preferred Stock has 660,000 shares authorized at a par value of $ 100 per share with an annual $ 3.75 cumulative dividend preference per share. There were 546,024 shares of Class A Preferred Stock outstanding as of both December 31, 2024 and 2023. Class B Serial Preferred Stock has 10,000,000 shares authorized at a par value of $ 1 per share. There were no shares of Class B Serial Preferred Stock outstanding as of both December 31, 2024 and 2023. </context> | us-gaap:PreferredStockParOrStatedValuePerShare |
As of December 31, 2024, there were 600,000,000 shares authorized at a par value of $ 1 per share, and 405,431,361 shares issued and outstanding. Dividends paid were $ 0.26 per share in 2024 ($ 0.05 per share in each of the first and second quarters of 2024 and $ 0.08 per share in each of the third and fourth quarter of 2024), $ 0.17 per share in 2023 ($ 0.04 per share in each of the first, second, and third quarters of 2023 and $ 0.05 per share in the fourth quarter of 2023), and $ 0.10 per share in 2022 ($ 0.02 per share in each of the first, second, and third quarters of 2022 and $ 0.04 per share in the fourth quarter of 2022). | text | 600000000 | sharesItemType | text: <entity> 600000000 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024, there were 600,000,000 shares authorized at a par value of $ 1 per share, and 405,431,361 shares issued and outstanding. Dividends paid were $ 0.26 per share in 2024 ($ 0.05 per share in each of the first and second quarters of 2024 and $ 0.08 per share in each of the third and fourth quarter of 2024), $ 0.17 per share in 2023 ($ 0.04 per share in each of the first, second, and third quarters of 2023 and $ 0.05 per share in the fourth quarter of 2023), and $ 0.10 per share in 2022 ($ 0.02 per share in each of the first, second, and third quarters of 2022 and $ 0.04 per share in the fourth quarter of 2022). </context> | us-gaap:CommonStockSharesAuthorized |
As of December 31, 2024, there were 600,000,000 shares authorized at a par value of $ 1 per share, and 405,431,361 shares issued and outstanding. Dividends paid were $ 0.26 per share in 2024 ($ 0.05 per share in each of the first and second quarters of 2024 and $ 0.08 per share in each of the third and fourth quarter of 2024), $ 0.17 per share in 2023 ($ 0.04 per share in each of the first, second, and third quarters of 2023 and $ 0.05 per share in the fourth quarter of 2023), and $ 0.10 per share in 2022 ($ 0.02 per share in each of the first, second, and third quarters of 2022 and $ 0.04 per share in the fourth quarter of 2022). | text | 1 | perShareItemType | text: <entity> 1 </entity> <entity type> perShareItemType </entity type> <context> As of December 31, 2024, there were 600,000,000 shares authorized at a par value of $ 1 per share, and 405,431,361 shares issued and outstanding. Dividends paid were $ 0.26 per share in 2024 ($ 0.05 per share in each of the first and second quarters of 2024 and $ 0.08 per share in each of the third and fourth quarter of 2024), $ 0.17 per share in 2023 ($ 0.04 per share in each of the first, second, and third quarters of 2023 and $ 0.05 per share in the fourth quarter of 2023), and $ 0.10 per share in 2022 ($ 0.02 per share in each of the first, second, and third quarters of 2022 and $ 0.04 per share in the fourth quarter of 2022). </context> | us-gaap:CommonStockParOrStatedValuePerShare |
As of December 31, 2024, there were 600,000,000 shares authorized at a par value of $ 1 per share, and 405,431,361 shares issued and outstanding. Dividends paid were $ 0.26 per share in 2024 ($ 0.05 per share in each of the first and second quarters of 2024 and $ 0.08 per share in each of the third and fourth quarter of 2024), $ 0.17 per share in 2023 ($ 0.04 per share in each of the first, second, and third quarters of 2023 and $ 0.05 per share in the fourth quarter of 2023), and $ 0.10 per share in 2022 ($ 0.02 per share in each of the first, second, and third quarters of 2022 and $ 0.04 per share in the fourth quarter of 2022). | text | 0.26 | perShareItemType | text: <entity> 0.26 </entity> <entity type> perShareItemType </entity type> <context> As of December 31, 2024, there were 600,000,000 shares authorized at a par value of $ 1 per share, and 405,431,361 shares issued and outstanding. Dividends paid were $ 0.26 per share in 2024 ($ 0.05 per share in each of the first and second quarters of 2024 and $ 0.08 per share in each of the third and fourth quarter of 2024), $ 0.17 per share in 2023 ($ 0.04 per share in each of the first, second, and third quarters of 2023 and $ 0.05 per share in the fourth quarter of 2023), and $ 0.10 per share in 2022 ($ 0.02 per share in each of the first, second, and third quarters of 2022 and $ 0.04 per share in the fourth quarter of 2022). </context> | us-gaap:CommonStockDividendsPerShareDeclared |
As of December 31, 2024, there were 600,000,000 shares authorized at a par value of $ 1 per share, and 405,431,361 shares issued and outstanding. Dividends paid were $ 0.26 per share in 2024 ($ 0.05 per share in each of the first and second quarters of 2024 and $ 0.08 per share in each of the third and fourth quarter of 2024), $ 0.17 per share in 2023 ($ 0.04 per share in each of the first, second, and third quarters of 2023 and $ 0.05 per share in the fourth quarter of 2023), and $ 0.10 per share in 2022 ($ 0.02 per share in each of the first, second, and third quarters of 2022 and $ 0.04 per share in the fourth quarter of 2022). | text | 0.17 | perShareItemType | text: <entity> 0.17 </entity> <entity type> perShareItemType </entity type> <context> As of December 31, 2024, there were 600,000,000 shares authorized at a par value of $ 1 per share, and 405,431,361 shares issued and outstanding. Dividends paid were $ 0.26 per share in 2024 ($ 0.05 per share in each of the first and second quarters of 2024 and $ 0.08 per share in each of the third and fourth quarter of 2024), $ 0.17 per share in 2023 ($ 0.04 per share in each of the first, second, and third quarters of 2023 and $ 0.05 per share in the fourth quarter of 2023), and $ 0.10 per share in 2022 ($ 0.02 per share in each of the first, second, and third quarters of 2022 and $ 0.04 per share in the fourth quarter of 2022). </context> | us-gaap:CommonStockDividendsPerShareDeclared |
As of December 31, 2024, there were 600,000,000 shares authorized at a par value of $ 1 per share, and 405,431,361 shares issued and outstanding. Dividends paid were $ 0.26 per share in 2024 ($ 0.05 per share in each of the first and second quarters of 2024 and $ 0.08 per share in each of the third and fourth quarter of 2024), $ 0.17 per share in 2023 ($ 0.04 per share in each of the first, second, and third quarters of 2023 and $ 0.05 per share in the fourth quarter of 2023), and $ 0.10 per share in 2022 ($ 0.02 per share in each of the first, second, and third quarters of 2022 and $ 0.04 per share in the fourth quarter of 2022). | text | 0.05 | perShareItemType | text: <entity> 0.05 </entity> <entity type> perShareItemType </entity type> <context> As of December 31, 2024, there were 600,000,000 shares authorized at a par value of $ 1 per share, and 405,431,361 shares issued and outstanding. Dividends paid were $ 0.26 per share in 2024 ($ 0.05 per share in each of the first and second quarters of 2024 and $ 0.08 per share in each of the third and fourth quarter of 2024), $ 0.17 per share in 2023 ($ 0.04 per share in each of the first, second, and third quarters of 2023 and $ 0.05 per share in the fourth quarter of 2023), and $ 0.10 per share in 2022 ($ 0.02 per share in each of the first, second, and third quarters of 2022 and $ 0.04 per share in the fourth quarter of 2022). </context> | us-gaap:CommonStockDividendsPerShareCashPaid |
As of December 31, 2024, there were 600,000,000 shares authorized at a par value of $ 1 per share, and 405,431,361 shares issued and outstanding. Dividends paid were $ 0.26 per share in 2024 ($ 0.05 per share in each of the first and second quarters of 2024 and $ 0.08 per share in each of the third and fourth quarter of 2024), $ 0.17 per share in 2023 ($ 0.04 per share in each of the first, second, and third quarters of 2023 and $ 0.05 per share in the fourth quarter of 2023), and $ 0.10 per share in 2022 ($ 0.02 per share in each of the first, second, and third quarters of 2022 and $ 0.04 per share in the fourth quarter of 2022). | text | 0.10 | perShareItemType | text: <entity> 0.10 </entity> <entity type> perShareItemType </entity type> <context> As of December 31, 2024, there were 600,000,000 shares authorized at a par value of $ 1 per share, and 405,431,361 shares issued and outstanding. Dividends paid were $ 0.26 per share in 2024 ($ 0.05 per share in each of the first and second quarters of 2024 and $ 0.08 per share in each of the third and fourth quarter of 2024), $ 0.17 per share in 2023 ($ 0.04 per share in each of the first, second, and third quarters of 2023 and $ 0.05 per share in the fourth quarter of 2023), and $ 0.10 per share in 2022 ($ 0.02 per share in each of the first, second, and third quarters of 2022 and $ 0.04 per share in the fourth quarter of 2022). </context> | us-gaap:CommonStockDividendsPerShareDeclared |
As of December 31, 2024, there were 600,000,000 shares authorized at a par value of $ 1 per share, and 405,431,361 shares issued and outstanding. Dividends paid were $ 0.26 per share in 2024 ($ 0.05 per share in each of the first and second quarters of 2024 and $ 0.08 per share in each of the third and fourth quarter of 2024), $ 0.17 per share in 2023 ($ 0.04 per share in each of the first, second, and third quarters of 2023 and $ 0.05 per share in the fourth quarter of 2023), and $ 0.10 per share in 2022 ($ 0.02 per share in each of the first, second, and third quarters of 2022 and $ 0.04 per share in the fourth quarter of 2022). | text | 0.04 | perShareItemType | text: <entity> 0.04 </entity> <entity type> perShareItemType </entity type> <context> As of December 31, 2024, there were 600,000,000 shares authorized at a par value of $ 1 per share, and 405,431,361 shares issued and outstanding. Dividends paid were $ 0.26 per share in 2024 ($ 0.05 per share in each of the first and second quarters of 2024 and $ 0.08 per share in each of the third and fourth quarter of 2024), $ 0.17 per share in 2023 ($ 0.04 per share in each of the first, second, and third quarters of 2023 and $ 0.05 per share in the fourth quarter of 2023), and $ 0.10 per share in 2022 ($ 0.02 per share in each of the first, second, and third quarters of 2022 and $ 0.04 per share in the fourth quarter of 2022). </context> | us-gaap:CommonStockDividendsPerShareCashPaid |
As of December 31, 2024, 47 million shares of common stock were reserved for issuance under Howmet’s stock-based compensation plans. As of December 31, 2024, 24 million shares remain available for issuance. Howmet issues new shares to satisfy the exercise of stock options and the conversion of stock awards. | text | 47 | sharesItemType | text: <entity> 47 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024, 47 million shares of common stock were reserved for issuance under Howmet’s stock-based compensation plans. As of December 31, 2024, 24 million shares remain available for issuance. Howmet issues new shares to satisfy the exercise of stock options and the conversion of stock awards. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
As of December 31, 2024, 47 million shares of common stock were reserved for issuance under Howmet’s stock-based compensation plans. As of December 31, 2024, 24 million shares remain available for issuance. Howmet issues new shares to satisfy the exercise of stock options and the conversion of stock awards. | text | 24 | sharesItemType | text: <entity> 24 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024, 47 million shares of common stock were reserved for issuance under Howmet’s stock-based compensation plans. As of December 31, 2024, 24 million shares remain available for issuance. Howmet issues new shares to satisfy the exercise of stock options and the conversion of stock awards. </context> | us-gaap:CommonStockCapitalSharesReservedForFutureIssuance |
The total value of shares repurchased during 2024, 2023, and 2022 were $ 500 , $ 250 , and $ 400 , respectively. All of the shares repurchased during 2024, 2023, and 2022 were immediately retired. The Company has a share repurchase program (the “Share Repurchase Program”) that, after giving effect to the additional $ 50 share repurchases made in January 2025 at an average price per share of $ 116.39 , retiring approximately 0.4 million shares, has approximately $ 2,147 in Board authorization remaining available as of January 31, 2025. The current Share Repurchase Program was authorized by the Company’s Board of Directors on August 18, 2021 at $ 1,500 , which was increased by the Board by $ 2,000 on July 30, 2024. Under the Company’s Share Repurchase Program, the Company may repurchase shares by means of trading plans established from time to time in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, block trades, private transactions, open market repurchases and/or accelerated share repurchase agreements, or other derivative transactions. There is no stated expiration for the Share Repurchase Program. Under its Share Repurchase Program, the Company may repurchase shares from time to time, in amounts, at prices, and at such times as the Company deems appropriate, subject to market conditions, legal requirements and other considerations. The Company is not obligated to repurchase any specific number of shares or to do so at any particular time, and the Share Repurchase Program may be suspended, modified, or terminated at any time without prior notice. | text | 500 | monetaryItemType | text: <entity> 500 </entity> <entity type> monetaryItemType </entity type> <context> The total value of shares repurchased during 2024, 2023, and 2022 were $ 500 , $ 250 , and $ 400 , respectively. All of the shares repurchased during 2024, 2023, and 2022 were immediately retired. The Company has a share repurchase program (the “Share Repurchase Program”) that, after giving effect to the additional $ 50 share repurchases made in January 2025 at an average price per share of $ 116.39 , retiring approximately 0.4 million shares, has approximately $ 2,147 in Board authorization remaining available as of January 31, 2025. The current Share Repurchase Program was authorized by the Company’s Board of Directors on August 18, 2021 at $ 1,500 , which was increased by the Board by $ 2,000 on July 30, 2024. Under the Company’s Share Repurchase Program, the Company may repurchase shares by means of trading plans established from time to time in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, block trades, private transactions, open market repurchases and/or accelerated share repurchase agreements, or other derivative transactions. There is no stated expiration for the Share Repurchase Program. Under its Share Repurchase Program, the Company may repurchase shares from time to time, in amounts, at prices, and at such times as the Company deems appropriate, subject to market conditions, legal requirements and other considerations. The Company is not obligated to repurchase any specific number of shares or to do so at any particular time, and the Share Repurchase Program may be suspended, modified, or terminated at any time without prior notice. </context> | us-gaap:StockRepurchasedDuringPeriodValue |
The total value of shares repurchased during 2024, 2023, and 2022 were $ 500 , $ 250 , and $ 400 , respectively. All of the shares repurchased during 2024, 2023, and 2022 were immediately retired. The Company has a share repurchase program (the “Share Repurchase Program”) that, after giving effect to the additional $ 50 share repurchases made in January 2025 at an average price per share of $ 116.39 , retiring approximately 0.4 million shares, has approximately $ 2,147 in Board authorization remaining available as of January 31, 2025. The current Share Repurchase Program was authorized by the Company’s Board of Directors on August 18, 2021 at $ 1,500 , which was increased by the Board by $ 2,000 on July 30, 2024. Under the Company’s Share Repurchase Program, the Company may repurchase shares by means of trading plans established from time to time in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, block trades, private transactions, open market repurchases and/or accelerated share repurchase agreements, or other derivative transactions. There is no stated expiration for the Share Repurchase Program. Under its Share Repurchase Program, the Company may repurchase shares from time to time, in amounts, at prices, and at such times as the Company deems appropriate, subject to market conditions, legal requirements and other considerations. The Company is not obligated to repurchase any specific number of shares or to do so at any particular time, and the Share Repurchase Program may be suspended, modified, or terminated at any time without prior notice. | text | 250 | monetaryItemType | text: <entity> 250 </entity> <entity type> monetaryItemType </entity type> <context> The total value of shares repurchased during 2024, 2023, and 2022 were $ 500 , $ 250 , and $ 400 , respectively. All of the shares repurchased during 2024, 2023, and 2022 were immediately retired. The Company has a share repurchase program (the “Share Repurchase Program”) that, after giving effect to the additional $ 50 share repurchases made in January 2025 at an average price per share of $ 116.39 , retiring approximately 0.4 million shares, has approximately $ 2,147 in Board authorization remaining available as of January 31, 2025. The current Share Repurchase Program was authorized by the Company’s Board of Directors on August 18, 2021 at $ 1,500 , which was increased by the Board by $ 2,000 on July 30, 2024. Under the Company’s Share Repurchase Program, the Company may repurchase shares by means of trading plans established from time to time in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, block trades, private transactions, open market repurchases and/or accelerated share repurchase agreements, or other derivative transactions. There is no stated expiration for the Share Repurchase Program. Under its Share Repurchase Program, the Company may repurchase shares from time to time, in amounts, at prices, and at such times as the Company deems appropriate, subject to market conditions, legal requirements and other considerations. The Company is not obligated to repurchase any specific number of shares or to do so at any particular time, and the Share Repurchase Program may be suspended, modified, or terminated at any time without prior notice. </context> | us-gaap:StockRepurchasedDuringPeriodValue |
The total value of shares repurchased during 2024, 2023, and 2022 were $ 500 , $ 250 , and $ 400 , respectively. All of the shares repurchased during 2024, 2023, and 2022 were immediately retired. The Company has a share repurchase program (the “Share Repurchase Program”) that, after giving effect to the additional $ 50 share repurchases made in January 2025 at an average price per share of $ 116.39 , retiring approximately 0.4 million shares, has approximately $ 2,147 in Board authorization remaining available as of January 31, 2025. The current Share Repurchase Program was authorized by the Company’s Board of Directors on August 18, 2021 at $ 1,500 , which was increased by the Board by $ 2,000 on July 30, 2024. Under the Company’s Share Repurchase Program, the Company may repurchase shares by means of trading plans established from time to time in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, block trades, private transactions, open market repurchases and/or accelerated share repurchase agreements, or other derivative transactions. There is no stated expiration for the Share Repurchase Program. Under its Share Repurchase Program, the Company may repurchase shares from time to time, in amounts, at prices, and at such times as the Company deems appropriate, subject to market conditions, legal requirements and other considerations. The Company is not obligated to repurchase any specific number of shares or to do so at any particular time, and the Share Repurchase Program may be suspended, modified, or terminated at any time without prior notice. | text | 400 | monetaryItemType | text: <entity> 400 </entity> <entity type> monetaryItemType </entity type> <context> The total value of shares repurchased during 2024, 2023, and 2022 were $ 500 , $ 250 , and $ 400 , respectively. All of the shares repurchased during 2024, 2023, and 2022 were immediately retired. The Company has a share repurchase program (the “Share Repurchase Program”) that, after giving effect to the additional $ 50 share repurchases made in January 2025 at an average price per share of $ 116.39 , retiring approximately 0.4 million shares, has approximately $ 2,147 in Board authorization remaining available as of January 31, 2025. The current Share Repurchase Program was authorized by the Company’s Board of Directors on August 18, 2021 at $ 1,500 , which was increased by the Board by $ 2,000 on July 30, 2024. Under the Company’s Share Repurchase Program, the Company may repurchase shares by means of trading plans established from time to time in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, block trades, private transactions, open market repurchases and/or accelerated share repurchase agreements, or other derivative transactions. There is no stated expiration for the Share Repurchase Program. Under its Share Repurchase Program, the Company may repurchase shares from time to time, in amounts, at prices, and at such times as the Company deems appropriate, subject to market conditions, legal requirements and other considerations. The Company is not obligated to repurchase any specific number of shares or to do so at any particular time, and the Share Repurchase Program may be suspended, modified, or terminated at any time without prior notice. </context> | us-gaap:StockRepurchasedDuringPeriodValue |
The total value of shares repurchased during 2024, 2023, and 2022 were $ 500 , $ 250 , and $ 400 , respectively. All of the shares repurchased during 2024, 2023, and 2022 were immediately retired. The Company has a share repurchase program (the “Share Repurchase Program”) that, after giving effect to the additional $ 50 share repurchases made in January 2025 at an average price per share of $ 116.39 , retiring approximately 0.4 million shares, has approximately $ 2,147 in Board authorization remaining available as of January 31, 2025. The current Share Repurchase Program was authorized by the Company’s Board of Directors on August 18, 2021 at $ 1,500 , which was increased by the Board by $ 2,000 on July 30, 2024. Under the Company’s Share Repurchase Program, the Company may repurchase shares by means of trading plans established from time to time in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, block trades, private transactions, open market repurchases and/or accelerated share repurchase agreements, or other derivative transactions. There is no stated expiration for the Share Repurchase Program. Under its Share Repurchase Program, the Company may repurchase shares from time to time, in amounts, at prices, and at such times as the Company deems appropriate, subject to market conditions, legal requirements and other considerations. The Company is not obligated to repurchase any specific number of shares or to do so at any particular time, and the Share Repurchase Program may be suspended, modified, or terminated at any time without prior notice. | text | 50 | monetaryItemType | text: <entity> 50 </entity> <entity type> monetaryItemType </entity type> <context> The total value of shares repurchased during 2024, 2023, and 2022 were $ 500 , $ 250 , and $ 400 , respectively. All of the shares repurchased during 2024, 2023, and 2022 were immediately retired. The Company has a share repurchase program (the “Share Repurchase Program”) that, after giving effect to the additional $ 50 share repurchases made in January 2025 at an average price per share of $ 116.39 , retiring approximately 0.4 million shares, has approximately $ 2,147 in Board authorization remaining available as of January 31, 2025. The current Share Repurchase Program was authorized by the Company’s Board of Directors on August 18, 2021 at $ 1,500 , which was increased by the Board by $ 2,000 on July 30, 2024. Under the Company’s Share Repurchase Program, the Company may repurchase shares by means of trading plans established from time to time in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, block trades, private transactions, open market repurchases and/or accelerated share repurchase agreements, or other derivative transactions. There is no stated expiration for the Share Repurchase Program. Under its Share Repurchase Program, the Company may repurchase shares from time to time, in amounts, at prices, and at such times as the Company deems appropriate, subject to market conditions, legal requirements and other considerations. The Company is not obligated to repurchase any specific number of shares or to do so at any particular time, and the Share Repurchase Program may be suspended, modified, or terminated at any time without prior notice. </context> | us-gaap:StockRepurchasedDuringPeriodValue |
The total value of shares repurchased during 2024, 2023, and 2022 were $ 500 , $ 250 , and $ 400 , respectively. All of the shares repurchased during 2024, 2023, and 2022 were immediately retired. The Company has a share repurchase program (the “Share Repurchase Program”) that, after giving effect to the additional $ 50 share repurchases made in January 2025 at an average price per share of $ 116.39 , retiring approximately 0.4 million shares, has approximately $ 2,147 in Board authorization remaining available as of January 31, 2025. The current Share Repurchase Program was authorized by the Company’s Board of Directors on August 18, 2021 at $ 1,500 , which was increased by the Board by $ 2,000 on July 30, 2024. Under the Company’s Share Repurchase Program, the Company may repurchase shares by means of trading plans established from time to time in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, block trades, private transactions, open market repurchases and/or accelerated share repurchase agreements, or other derivative transactions. There is no stated expiration for the Share Repurchase Program. Under its Share Repurchase Program, the Company may repurchase shares from time to time, in amounts, at prices, and at such times as the Company deems appropriate, subject to market conditions, legal requirements and other considerations. The Company is not obligated to repurchase any specific number of shares or to do so at any particular time, and the Share Repurchase Program may be suspended, modified, or terminated at any time without prior notice. | text | 116.39 | perShareItemType | text: <entity> 116.39 </entity> <entity type> perShareItemType </entity type> <context> The total value of shares repurchased during 2024, 2023, and 2022 were $ 500 , $ 250 , and $ 400 , respectively. All of the shares repurchased during 2024, 2023, and 2022 were immediately retired. The Company has a share repurchase program (the “Share Repurchase Program”) that, after giving effect to the additional $ 50 share repurchases made in January 2025 at an average price per share of $ 116.39 , retiring approximately 0.4 million shares, has approximately $ 2,147 in Board authorization remaining available as of January 31, 2025. The current Share Repurchase Program was authorized by the Company’s Board of Directors on August 18, 2021 at $ 1,500 , which was increased by the Board by $ 2,000 on July 30, 2024. Under the Company’s Share Repurchase Program, the Company may repurchase shares by means of trading plans established from time to time in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, block trades, private transactions, open market repurchases and/or accelerated share repurchase agreements, or other derivative transactions. There is no stated expiration for the Share Repurchase Program. Under its Share Repurchase Program, the Company may repurchase shares from time to time, in amounts, at prices, and at such times as the Company deems appropriate, subject to market conditions, legal requirements and other considerations. The Company is not obligated to repurchase any specific number of shares or to do so at any particular time, and the Share Repurchase Program may be suspended, modified, or terminated at any time without prior notice. </context> | us-gaap:TreasuryStockAcquiredAverageCostPerShare |
The total value of shares repurchased during 2024, 2023, and 2022 were $ 500 , $ 250 , and $ 400 , respectively. All of the shares repurchased during 2024, 2023, and 2022 were immediately retired. The Company has a share repurchase program (the “Share Repurchase Program”) that, after giving effect to the additional $ 50 share repurchases made in January 2025 at an average price per share of $ 116.39 , retiring approximately 0.4 million shares, has approximately $ 2,147 in Board authorization remaining available as of January 31, 2025. The current Share Repurchase Program was authorized by the Company’s Board of Directors on August 18, 2021 at $ 1,500 , which was increased by the Board by $ 2,000 on July 30, 2024. Under the Company’s Share Repurchase Program, the Company may repurchase shares by means of trading plans established from time to time in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, block trades, private transactions, open market repurchases and/or accelerated share repurchase agreements, or other derivative transactions. There is no stated expiration for the Share Repurchase Program. Under its Share Repurchase Program, the Company may repurchase shares from time to time, in amounts, at prices, and at such times as the Company deems appropriate, subject to market conditions, legal requirements and other considerations. The Company is not obligated to repurchase any specific number of shares or to do so at any particular time, and the Share Repurchase Program may be suspended, modified, or terminated at any time without prior notice. | text | 0.4 | sharesItemType | text: <entity> 0.4 </entity> <entity type> sharesItemType </entity type> <context> The total value of shares repurchased during 2024, 2023, and 2022 were $ 500 , $ 250 , and $ 400 , respectively. All of the shares repurchased during 2024, 2023, and 2022 were immediately retired. The Company has a share repurchase program (the “Share Repurchase Program”) that, after giving effect to the additional $ 50 share repurchases made in January 2025 at an average price per share of $ 116.39 , retiring approximately 0.4 million shares, has approximately $ 2,147 in Board authorization remaining available as of January 31, 2025. The current Share Repurchase Program was authorized by the Company’s Board of Directors on August 18, 2021 at $ 1,500 , which was increased by the Board by $ 2,000 on July 30, 2024. Under the Company’s Share Repurchase Program, the Company may repurchase shares by means of trading plans established from time to time in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, block trades, private transactions, open market repurchases and/or accelerated share repurchase agreements, or other derivative transactions. There is no stated expiration for the Share Repurchase Program. Under its Share Repurchase Program, the Company may repurchase shares from time to time, in amounts, at prices, and at such times as the Company deems appropriate, subject to market conditions, legal requirements and other considerations. The Company is not obligated to repurchase any specific number of shares or to do so at any particular time, and the Share Repurchase Program may be suspended, modified, or terminated at any time without prior notice. </context> | us-gaap:StockRepurchasedAndRetiredDuringPeriodShares |
The total value of shares repurchased during 2024, 2023, and 2022 were $ 500 , $ 250 , and $ 400 , respectively. All of the shares repurchased during 2024, 2023, and 2022 were immediately retired. The Company has a share repurchase program (the “Share Repurchase Program”) that, after giving effect to the additional $ 50 share repurchases made in January 2025 at an average price per share of $ 116.39 , retiring approximately 0.4 million shares, has approximately $ 2,147 in Board authorization remaining available as of January 31, 2025. The current Share Repurchase Program was authorized by the Company’s Board of Directors on August 18, 2021 at $ 1,500 , which was increased by the Board by $ 2,000 on July 30, 2024. Under the Company’s Share Repurchase Program, the Company may repurchase shares by means of trading plans established from time to time in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, block trades, private transactions, open market repurchases and/or accelerated share repurchase agreements, or other derivative transactions. There is no stated expiration for the Share Repurchase Program. Under its Share Repurchase Program, the Company may repurchase shares from time to time, in amounts, at prices, and at such times as the Company deems appropriate, subject to market conditions, legal requirements and other considerations. The Company is not obligated to repurchase any specific number of shares or to do so at any particular time, and the Share Repurchase Program may be suspended, modified, or terminated at any time without prior notice. | text | 2147 | monetaryItemType | text: <entity> 2147 </entity> <entity type> monetaryItemType </entity type> <context> The total value of shares repurchased during 2024, 2023, and 2022 were $ 500 , $ 250 , and $ 400 , respectively. All of the shares repurchased during 2024, 2023, and 2022 were immediately retired. The Company has a share repurchase program (the “Share Repurchase Program”) that, after giving effect to the additional $ 50 share repurchases made in January 2025 at an average price per share of $ 116.39 , retiring approximately 0.4 million shares, has approximately $ 2,147 in Board authorization remaining available as of January 31, 2025. The current Share Repurchase Program was authorized by the Company’s Board of Directors on August 18, 2021 at $ 1,500 , which was increased by the Board by $ 2,000 on July 30, 2024. Under the Company’s Share Repurchase Program, the Company may repurchase shares by means of trading plans established from time to time in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, block trades, private transactions, open market repurchases and/or accelerated share repurchase agreements, or other derivative transactions. There is no stated expiration for the Share Repurchase Program. Under its Share Repurchase Program, the Company may repurchase shares from time to time, in amounts, at prices, and at such times as the Company deems appropriate, subject to market conditions, legal requirements and other considerations. The Company is not obligated to repurchase any specific number of shares or to do so at any particular time, and the Share Repurchase Program may be suspended, modified, or terminated at any time without prior notice. </context> | us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 |
In 2024, 2023, and 2022, Howmet recognized stock-based compensation expense of $ 63 ($ 57 after-tax), $ 50 ($ 44 after-tax), and $ 54 ($ 49 after-tax), respectively. Senior executive performance awards granted in April 2020 were modified in June 2020, resulting in incremental compensation expense of $ 12 , which was amortized over the remaining service period that ended April 1, 2023. | text | 63 | monetaryItemType | text: <entity> 63 </entity> <entity type> monetaryItemType </entity type> <context> In 2024, 2023, and 2022, Howmet recognized stock-based compensation expense of $ 63 ($ 57 after-tax), $ 50 ($ 44 after-tax), and $ 54 ($ 49 after-tax), respectively. Senior executive performance awards granted in April 2020 were modified in June 2020, resulting in incremental compensation expense of $ 12 , which was amortized over the remaining service period that ended April 1, 2023. </context> | us-gaap:ShareBasedCompensation |
In 2024, 2023, and 2022, Howmet recognized stock-based compensation expense of $ 63 ($ 57 after-tax), $ 50 ($ 44 after-tax), and $ 54 ($ 49 after-tax), respectively. Senior executive performance awards granted in April 2020 were modified in June 2020, resulting in incremental compensation expense of $ 12 , which was amortized over the remaining service period that ended April 1, 2023. | text | 57 | monetaryItemType | text: <entity> 57 </entity> <entity type> monetaryItemType </entity type> <context> In 2024, 2023, and 2022, Howmet recognized stock-based compensation expense of $ 63 ($ 57 after-tax), $ 50 ($ 44 after-tax), and $ 54 ($ 49 after-tax), respectively. Senior executive performance awards granted in April 2020 were modified in June 2020, resulting in incremental compensation expense of $ 12 , which was amortized over the remaining service period that ended April 1, 2023. </context> | us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax |
In 2024, 2023, and 2022, Howmet recognized stock-based compensation expense of $ 63 ($ 57 after-tax), $ 50 ($ 44 after-tax), and $ 54 ($ 49 after-tax), respectively. Senior executive performance awards granted in April 2020 were modified in June 2020, resulting in incremental compensation expense of $ 12 , which was amortized over the remaining service period that ended April 1, 2023. | text | 50 | monetaryItemType | text: <entity> 50 </entity> <entity type> monetaryItemType </entity type> <context> In 2024, 2023, and 2022, Howmet recognized stock-based compensation expense of $ 63 ($ 57 after-tax), $ 50 ($ 44 after-tax), and $ 54 ($ 49 after-tax), respectively. Senior executive performance awards granted in April 2020 were modified in June 2020, resulting in incremental compensation expense of $ 12 , which was amortized over the remaining service period that ended April 1, 2023. </context> | us-gaap:ShareBasedCompensation |
In 2024, 2023, and 2022, Howmet recognized stock-based compensation expense of $ 63 ($ 57 after-tax), $ 50 ($ 44 after-tax), and $ 54 ($ 49 after-tax), respectively. Senior executive performance awards granted in April 2020 were modified in June 2020, resulting in incremental compensation expense of $ 12 , which was amortized over the remaining service period that ended April 1, 2023. | text | 44 | monetaryItemType | text: <entity> 44 </entity> <entity type> monetaryItemType </entity type> <context> In 2024, 2023, and 2022, Howmet recognized stock-based compensation expense of $ 63 ($ 57 after-tax), $ 50 ($ 44 after-tax), and $ 54 ($ 49 after-tax), respectively. Senior executive performance awards granted in April 2020 were modified in June 2020, resulting in incremental compensation expense of $ 12 , which was amortized over the remaining service period that ended April 1, 2023. </context> | us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax |
In 2024, 2023, and 2022, Howmet recognized stock-based compensation expense of $ 63 ($ 57 after-tax), $ 50 ($ 44 after-tax), and $ 54 ($ 49 after-tax), respectively. Senior executive performance awards granted in April 2020 were modified in June 2020, resulting in incremental compensation expense of $ 12 , which was amortized over the remaining service period that ended April 1, 2023. | text | 54 | monetaryItemType | text: <entity> 54 </entity> <entity type> monetaryItemType </entity type> <context> In 2024, 2023, and 2022, Howmet recognized stock-based compensation expense of $ 63 ($ 57 after-tax), $ 50 ($ 44 after-tax), and $ 54 ($ 49 after-tax), respectively. Senior executive performance awards granted in April 2020 were modified in June 2020, resulting in incremental compensation expense of $ 12 , which was amortized over the remaining service period that ended April 1, 2023. </context> | us-gaap:ShareBasedCompensation |
In 2024, 2023, and 2022, Howmet recognized stock-based compensation expense of $ 63 ($ 57 after-tax), $ 50 ($ 44 after-tax), and $ 54 ($ 49 after-tax), respectively. Senior executive performance awards granted in April 2020 were modified in June 2020, resulting in incremental compensation expense of $ 12 , which was amortized over the remaining service period that ended April 1, 2023. | text | 49 | monetaryItemType | text: <entity> 49 </entity> <entity type> monetaryItemType </entity type> <context> In 2024, 2023, and 2022, Howmet recognized stock-based compensation expense of $ 63 ($ 57 after-tax), $ 50 ($ 44 after-tax), and $ 54 ($ 49 after-tax), respectively. Senior executive performance awards granted in April 2020 were modified in June 2020, resulting in incremental compensation expense of $ 12 , which was amortized over the remaining service period that ended April 1, 2023. </context> | us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax |
In 2024, 2023, and 2022, Howmet recognized stock-based compensation expense of $ 63 ($ 57 after-tax), $ 50 ($ 44 after-tax), and $ 54 ($ 49 after-tax), respectively. Senior executive performance awards granted in April 2020 were modified in June 2020, resulting in incremental compensation expense of $ 12 , which was amortized over the remaining service period that ended April 1, 2023. | text | 12 | monetaryItemType | text: <entity> 12 </entity> <entity type> monetaryItemType </entity type> <context> In 2024, 2023, and 2022, Howmet recognized stock-based compensation expense of $ 63 ($ 57 after-tax), $ 50 ($ 44 after-tax), and $ 54 ($ 49 after-tax), respectively. Senior executive performance awards granted in April 2020 were modified in June 2020, resulting in incremental compensation expense of $ 12 , which was amortized over the remaining service period that ended April 1, 2023. </context> | us-gaap:ShareBasedCompensation |
All stock-based compensation expense recorded in 2024, 2023, and 2022 relates to restricted stock unit awards. No stock-based compensation expense was capitalized in any of those years. As of December 31, 2024, there was $ 28 (pre-tax) of unrecognized compensation expense related to non-vested restricted stock unit award grants. This expense is expected to be recognized over a weighted average period of 1.6 years. | text | 28 | monetaryItemType | text: <entity> 28 </entity> <entity type> monetaryItemType </entity type> <context> All stock-based compensation expense recorded in 2024, 2023, and 2022 relates to restricted stock unit awards. No stock-based compensation expense was capitalized in any of those years. As of December 31, 2024, there was $ 28 (pre-tax) of unrecognized compensation expense related to non-vested restricted stock unit award grants. This expense is expected to be recognized over a weighted average period of 1.6 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
Stock-based compensation expense is based on the grant date fair value of the applicable equity grant. For restricted stock unit awards, the fair value is equivalent to the closing market price of Howmet’s common stock on the date of grant. The weighted average grant date fair value per share of the 2024, 2023, and 2022 performance stock awards with a market condition including a TSR component is $ 72.65 , $ 47.59 , and $ 44.44 , respectively. The 2024, 2023, and 2022 performance awards were valued using a Monte Carlo model. A Monte Carlo simulation uses assumptions of stock price behavior to estimate the probability of satisfying market conditions and the resulting fair value of the award. The risk-free interest rate ( 4.4 % in 2024, 4.4 % in 2023, and 2.0 % in 2022) was based on a yield curve of interest rates at the time of the grant based on the remaining performance period. In 2024, 2023, and 2022, volatility of 27.7 %, 39.0 %, and 39.4 %, respectively, was estimated using Howmet's historical volatility. Stock options were last granted in 2018. | text | 72.65 | perShareItemType | text: <entity> 72.65 </entity> <entity type> perShareItemType </entity type> <context> Stock-based compensation expense is based on the grant date fair value of the applicable equity grant. For restricted stock unit awards, the fair value is equivalent to the closing market price of Howmet’s common stock on the date of grant. The weighted average grant date fair value per share of the 2024, 2023, and 2022 performance stock awards with a market condition including a TSR component is $ 72.65 , $ 47.59 , and $ 44.44 , respectively. The 2024, 2023, and 2022 performance awards were valued using a Monte Carlo model. A Monte Carlo simulation uses assumptions of stock price behavior to estimate the probability of satisfying market conditions and the resulting fair value of the award. The risk-free interest rate ( 4.4 % in 2024, 4.4 % in 2023, and 2.0 % in 2022) was based on a yield curve of interest rates at the time of the grant based on the remaining performance period. In 2024, 2023, and 2022, volatility of 27.7 %, 39.0 %, and 39.4 %, respectively, was estimated using Howmet's historical volatility. Stock options were last granted in 2018. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
Stock-based compensation expense is based on the grant date fair value of the applicable equity grant. For restricted stock unit awards, the fair value is equivalent to the closing market price of Howmet’s common stock on the date of grant. The weighted average grant date fair value per share of the 2024, 2023, and 2022 performance stock awards with a market condition including a TSR component is $ 72.65 , $ 47.59 , and $ 44.44 , respectively. The 2024, 2023, and 2022 performance awards were valued using a Monte Carlo model. A Monte Carlo simulation uses assumptions of stock price behavior to estimate the probability of satisfying market conditions and the resulting fair value of the award. The risk-free interest rate ( 4.4 % in 2024, 4.4 % in 2023, and 2.0 % in 2022) was based on a yield curve of interest rates at the time of the grant based on the remaining performance period. In 2024, 2023, and 2022, volatility of 27.7 %, 39.0 %, and 39.4 %, respectively, was estimated using Howmet's historical volatility. Stock options were last granted in 2018. | text | 47.59 | perShareItemType | text: <entity> 47.59 </entity> <entity type> perShareItemType </entity type> <context> Stock-based compensation expense is based on the grant date fair value of the applicable equity grant. For restricted stock unit awards, the fair value is equivalent to the closing market price of Howmet’s common stock on the date of grant. The weighted average grant date fair value per share of the 2024, 2023, and 2022 performance stock awards with a market condition including a TSR component is $ 72.65 , $ 47.59 , and $ 44.44 , respectively. The 2024, 2023, and 2022 performance awards were valued using a Monte Carlo model. A Monte Carlo simulation uses assumptions of stock price behavior to estimate the probability of satisfying market conditions and the resulting fair value of the award. The risk-free interest rate ( 4.4 % in 2024, 4.4 % in 2023, and 2.0 % in 2022) was based on a yield curve of interest rates at the time of the grant based on the remaining performance period. In 2024, 2023, and 2022, volatility of 27.7 %, 39.0 %, and 39.4 %, respectively, was estimated using Howmet's historical volatility. Stock options were last granted in 2018. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
Stock-based compensation expense is based on the grant date fair value of the applicable equity grant. For restricted stock unit awards, the fair value is equivalent to the closing market price of Howmet’s common stock on the date of grant. The weighted average grant date fair value per share of the 2024, 2023, and 2022 performance stock awards with a market condition including a TSR component is $ 72.65 , $ 47.59 , and $ 44.44 , respectively. The 2024, 2023, and 2022 performance awards were valued using a Monte Carlo model. A Monte Carlo simulation uses assumptions of stock price behavior to estimate the probability of satisfying market conditions and the resulting fair value of the award. The risk-free interest rate ( 4.4 % in 2024, 4.4 % in 2023, and 2.0 % in 2022) was based on a yield curve of interest rates at the time of the grant based on the remaining performance period. In 2024, 2023, and 2022, volatility of 27.7 %, 39.0 %, and 39.4 %, respectively, was estimated using Howmet's historical volatility. Stock options were last granted in 2018. | text | 44.44 | perShareItemType | text: <entity> 44.44 </entity> <entity type> perShareItemType </entity type> <context> Stock-based compensation expense is based on the grant date fair value of the applicable equity grant. For restricted stock unit awards, the fair value is equivalent to the closing market price of Howmet’s common stock on the date of grant. The weighted average grant date fair value per share of the 2024, 2023, and 2022 performance stock awards with a market condition including a TSR component is $ 72.65 , $ 47.59 , and $ 44.44 , respectively. The 2024, 2023, and 2022 performance awards were valued using a Monte Carlo model. A Monte Carlo simulation uses assumptions of stock price behavior to estimate the probability of satisfying market conditions and the resulting fair value of the award. The risk-free interest rate ( 4.4 % in 2024, 4.4 % in 2023, and 2.0 % in 2022) was based on a yield curve of interest rates at the time of the grant based on the remaining performance period. In 2024, 2023, and 2022, volatility of 27.7 %, 39.0 %, and 39.4 %, respectively, was estimated using Howmet's historical volatility. Stock options were last granted in 2018. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
Stock-based compensation expense is based on the grant date fair value of the applicable equity grant. For restricted stock unit awards, the fair value is equivalent to the closing market price of Howmet’s common stock on the date of grant. The weighted average grant date fair value per share of the 2024, 2023, and 2022 performance stock awards with a market condition including a TSR component is $ 72.65 , $ 47.59 , and $ 44.44 , respectively. The 2024, 2023, and 2022 performance awards were valued using a Monte Carlo model. A Monte Carlo simulation uses assumptions of stock price behavior to estimate the probability of satisfying market conditions and the resulting fair value of the award. The risk-free interest rate ( 4.4 % in 2024, 4.4 % in 2023, and 2.0 % in 2022) was based on a yield curve of interest rates at the time of the grant based on the remaining performance period. In 2024, 2023, and 2022, volatility of 27.7 %, 39.0 %, and 39.4 %, respectively, was estimated using Howmet's historical volatility. Stock options were last granted in 2018. | text | 4.4 | percentItemType | text: <entity> 4.4 </entity> <entity type> percentItemType </entity type> <context> Stock-based compensation expense is based on the grant date fair value of the applicable equity grant. For restricted stock unit awards, the fair value is equivalent to the closing market price of Howmet’s common stock on the date of grant. The weighted average grant date fair value per share of the 2024, 2023, and 2022 performance stock awards with a market condition including a TSR component is $ 72.65 , $ 47.59 , and $ 44.44 , respectively. The 2024, 2023, and 2022 performance awards were valued using a Monte Carlo model. A Monte Carlo simulation uses assumptions of stock price behavior to estimate the probability of satisfying market conditions and the resulting fair value of the award. The risk-free interest rate ( 4.4 % in 2024, 4.4 % in 2023, and 2.0 % in 2022) was based on a yield curve of interest rates at the time of the grant based on the remaining performance period. In 2024, 2023, and 2022, volatility of 27.7 %, 39.0 %, and 39.4 %, respectively, was estimated using Howmet's historical volatility. Stock options were last granted in 2018. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate |
Stock-based compensation expense is based on the grant date fair value of the applicable equity grant. For restricted stock unit awards, the fair value is equivalent to the closing market price of Howmet’s common stock on the date of grant. The weighted average grant date fair value per share of the 2024, 2023, and 2022 performance stock awards with a market condition including a TSR component is $ 72.65 , $ 47.59 , and $ 44.44 , respectively. The 2024, 2023, and 2022 performance awards were valued using a Monte Carlo model. A Monte Carlo simulation uses assumptions of stock price behavior to estimate the probability of satisfying market conditions and the resulting fair value of the award. The risk-free interest rate ( 4.4 % in 2024, 4.4 % in 2023, and 2.0 % in 2022) was based on a yield curve of interest rates at the time of the grant based on the remaining performance period. In 2024, 2023, and 2022, volatility of 27.7 %, 39.0 %, and 39.4 %, respectively, was estimated using Howmet's historical volatility. Stock options were last granted in 2018. | text | 2.0 | percentItemType | text: <entity> 2.0 </entity> <entity type> percentItemType </entity type> <context> Stock-based compensation expense is based on the grant date fair value of the applicable equity grant. For restricted stock unit awards, the fair value is equivalent to the closing market price of Howmet’s common stock on the date of grant. The weighted average grant date fair value per share of the 2024, 2023, and 2022 performance stock awards with a market condition including a TSR component is $ 72.65 , $ 47.59 , and $ 44.44 , respectively. The 2024, 2023, and 2022 performance awards were valued using a Monte Carlo model. A Monte Carlo simulation uses assumptions of stock price behavior to estimate the probability of satisfying market conditions and the resulting fair value of the award. The risk-free interest rate ( 4.4 % in 2024, 4.4 % in 2023, and 2.0 % in 2022) was based on a yield curve of interest rates at the time of the grant based on the remaining performance period. In 2024, 2023, and 2022, volatility of 27.7 %, 39.0 %, and 39.4 %, respectively, was estimated using Howmet's historical volatility. Stock options were last granted in 2018. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate |
Stock-based compensation expense is based on the grant date fair value of the applicable equity grant. For restricted stock unit awards, the fair value is equivalent to the closing market price of Howmet’s common stock on the date of grant. The weighted average grant date fair value per share of the 2024, 2023, and 2022 performance stock awards with a market condition including a TSR component is $ 72.65 , $ 47.59 , and $ 44.44 , respectively. The 2024, 2023, and 2022 performance awards were valued using a Monte Carlo model. A Monte Carlo simulation uses assumptions of stock price behavior to estimate the probability of satisfying market conditions and the resulting fair value of the award. The risk-free interest rate ( 4.4 % in 2024, 4.4 % in 2023, and 2.0 % in 2022) was based on a yield curve of interest rates at the time of the grant based on the remaining performance period. In 2024, 2023, and 2022, volatility of 27.7 %, 39.0 %, and 39.4 %, respectively, was estimated using Howmet's historical volatility. Stock options were last granted in 2018. | text | 27.7 | percentItemType | text: <entity> 27.7 </entity> <entity type> percentItemType </entity type> <context> Stock-based compensation expense is based on the grant date fair value of the applicable equity grant. For restricted stock unit awards, the fair value is equivalent to the closing market price of Howmet’s common stock on the date of grant. The weighted average grant date fair value per share of the 2024, 2023, and 2022 performance stock awards with a market condition including a TSR component is $ 72.65 , $ 47.59 , and $ 44.44 , respectively. The 2024, 2023, and 2022 performance awards were valued using a Monte Carlo model. A Monte Carlo simulation uses assumptions of stock price behavior to estimate the probability of satisfying market conditions and the resulting fair value of the award. The risk-free interest rate ( 4.4 % in 2024, 4.4 % in 2023, and 2.0 % in 2022) was based on a yield curve of interest rates at the time of the grant based on the remaining performance period. In 2024, 2023, and 2022, volatility of 27.7 %, 39.0 %, and 39.4 %, respectively, was estimated using Howmet's historical volatility. Stock options were last granted in 2018. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate |
Stock-based compensation expense is based on the grant date fair value of the applicable equity grant. For restricted stock unit awards, the fair value is equivalent to the closing market price of Howmet’s common stock on the date of grant. The weighted average grant date fair value per share of the 2024, 2023, and 2022 performance stock awards with a market condition including a TSR component is $ 72.65 , $ 47.59 , and $ 44.44 , respectively. The 2024, 2023, and 2022 performance awards were valued using a Monte Carlo model. A Monte Carlo simulation uses assumptions of stock price behavior to estimate the probability of satisfying market conditions and the resulting fair value of the award. The risk-free interest rate ( 4.4 % in 2024, 4.4 % in 2023, and 2.0 % in 2022) was based on a yield curve of interest rates at the time of the grant based on the remaining performance period. In 2024, 2023, and 2022, volatility of 27.7 %, 39.0 %, and 39.4 %, respectively, was estimated using Howmet's historical volatility. Stock options were last granted in 2018. | text | 39.0 | percentItemType | text: <entity> 39.0 </entity> <entity type> percentItemType </entity type> <context> Stock-based compensation expense is based on the grant date fair value of the applicable equity grant. For restricted stock unit awards, the fair value is equivalent to the closing market price of Howmet’s common stock on the date of grant. The weighted average grant date fair value per share of the 2024, 2023, and 2022 performance stock awards with a market condition including a TSR component is $ 72.65 , $ 47.59 , and $ 44.44 , respectively. The 2024, 2023, and 2022 performance awards were valued using a Monte Carlo model. A Monte Carlo simulation uses assumptions of stock price behavior to estimate the probability of satisfying market conditions and the resulting fair value of the award. The risk-free interest rate ( 4.4 % in 2024, 4.4 % in 2023, and 2.0 % in 2022) was based on a yield curve of interest rates at the time of the grant based on the remaining performance period. In 2024, 2023, and 2022, volatility of 27.7 %, 39.0 %, and 39.4 %, respectively, was estimated using Howmet's historical volatility. Stock options were last granted in 2018. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate |
Stock-based compensation expense is based on the grant date fair value of the applicable equity grant. For restricted stock unit awards, the fair value is equivalent to the closing market price of Howmet’s common stock on the date of grant. The weighted average grant date fair value per share of the 2024, 2023, and 2022 performance stock awards with a market condition including a TSR component is $ 72.65 , $ 47.59 , and $ 44.44 , respectively. The 2024, 2023, and 2022 performance awards were valued using a Monte Carlo model. A Monte Carlo simulation uses assumptions of stock price behavior to estimate the probability of satisfying market conditions and the resulting fair value of the award. The risk-free interest rate ( 4.4 % in 2024, 4.4 % in 2023, and 2.0 % in 2022) was based on a yield curve of interest rates at the time of the grant based on the remaining performance period. In 2024, 2023, and 2022, volatility of 27.7 %, 39.0 %, and 39.4 %, respectively, was estimated using Howmet's historical volatility. Stock options were last granted in 2018. | text | 39.4 | percentItemType | text: <entity> 39.4 </entity> <entity type> percentItemType </entity type> <context> Stock-based compensation expense is based on the grant date fair value of the applicable equity grant. For restricted stock unit awards, the fair value is equivalent to the closing market price of Howmet’s common stock on the date of grant. The weighted average grant date fair value per share of the 2024, 2023, and 2022 performance stock awards with a market condition including a TSR component is $ 72.65 , $ 47.59 , and $ 44.44 , respectively. The 2024, 2023, and 2022 performance awards were valued using a Monte Carlo model. A Monte Carlo simulation uses assumptions of stock price behavior to estimate the probability of satisfying market conditions and the resulting fair value of the award. The risk-free interest rate ( 4.4 % in 2024, 4.4 % in 2023, and 2.0 % in 2022) was based on a yield curve of interest rates at the time of the grant based on the remaining performance period. In 2024, 2023, and 2022, volatility of 27.7 %, 39.0 %, and 39.4 %, respectively, was estimated using Howmet's historical volatility. Stock options were last granted in 2018. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate |
As of December 31, 2024, the stock options outstanding had a weighted average remaining contractual life of 2.1 and a total intrinsic value of $ 13 . All of the stock options outstanding were fully vested and exercisable. In 2024, 2023, and 2022, the cash received from stock option exercises was $ 8 , $ 11 , and $ 16 , respectively, and the total tax benefit realized from these exercises was $ 3 , $ 2 , and $ 2 , respectively. The total intrinsic value of stock options exercised during 2024, 2023, and 2022 was $ 16 , $ 9 , and $ 10 , respectively. The total intrinsic value of stock awards converted during 2024, 2023, and 2022 was $ 117 , $ 187 , and $ 61 , respectively. | text | 13 | monetaryItemType | text: <entity> 13 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the stock options outstanding had a weighted average remaining contractual life of 2.1 and a total intrinsic value of $ 13 . All of the stock options outstanding were fully vested and exercisable. In 2024, 2023, and 2022, the cash received from stock option exercises was $ 8 , $ 11 , and $ 16 , respectively, and the total tax benefit realized from these exercises was $ 3 , $ 2 , and $ 2 , respectively. The total intrinsic value of stock options exercised during 2024, 2023, and 2022 was $ 16 , $ 9 , and $ 10 , respectively. The total intrinsic value of stock awards converted during 2024, 2023, and 2022 was $ 117 , $ 187 , and $ 61 , respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue |
As of December 31, 2024, the stock options outstanding had a weighted average remaining contractual life of 2.1 and a total intrinsic value of $ 13 . All of the stock options outstanding were fully vested and exercisable. In 2024, 2023, and 2022, the cash received from stock option exercises was $ 8 , $ 11 , and $ 16 , respectively, and the total tax benefit realized from these exercises was $ 3 , $ 2 , and $ 2 , respectively. The total intrinsic value of stock options exercised during 2024, 2023, and 2022 was $ 16 , $ 9 , and $ 10 , respectively. The total intrinsic value of stock awards converted during 2024, 2023, and 2022 was $ 117 , $ 187 , and $ 61 , respectively. | text | 8 | monetaryItemType | text: <entity> 8 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the stock options outstanding had a weighted average remaining contractual life of 2.1 and a total intrinsic value of $ 13 . All of the stock options outstanding were fully vested and exercisable. In 2024, 2023, and 2022, the cash received from stock option exercises was $ 8 , $ 11 , and $ 16 , respectively, and the total tax benefit realized from these exercises was $ 3 , $ 2 , and $ 2 , respectively. The total intrinsic value of stock options exercised during 2024, 2023, and 2022 was $ 16 , $ 9 , and $ 10 , respectively. The total intrinsic value of stock awards converted during 2024, 2023, and 2022 was $ 117 , $ 187 , and $ 61 , respectively. </context> | us-gaap:ProceedsFromStockOptionsExercised |
As of December 31, 2024, the stock options outstanding had a weighted average remaining contractual life of 2.1 and a total intrinsic value of $ 13 . All of the stock options outstanding were fully vested and exercisable. In 2024, 2023, and 2022, the cash received from stock option exercises was $ 8 , $ 11 , and $ 16 , respectively, and the total tax benefit realized from these exercises was $ 3 , $ 2 , and $ 2 , respectively. The total intrinsic value of stock options exercised during 2024, 2023, and 2022 was $ 16 , $ 9 , and $ 10 , respectively. The total intrinsic value of stock awards converted during 2024, 2023, and 2022 was $ 117 , $ 187 , and $ 61 , respectively. | text | 11 | monetaryItemType | text: <entity> 11 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the stock options outstanding had a weighted average remaining contractual life of 2.1 and a total intrinsic value of $ 13 . All of the stock options outstanding were fully vested and exercisable. In 2024, 2023, and 2022, the cash received from stock option exercises was $ 8 , $ 11 , and $ 16 , respectively, and the total tax benefit realized from these exercises was $ 3 , $ 2 , and $ 2 , respectively. The total intrinsic value of stock options exercised during 2024, 2023, and 2022 was $ 16 , $ 9 , and $ 10 , respectively. The total intrinsic value of stock awards converted during 2024, 2023, and 2022 was $ 117 , $ 187 , and $ 61 , respectively. </context> | us-gaap:ProceedsFromStockOptionsExercised |
As of December 31, 2024, the stock options outstanding had a weighted average remaining contractual life of 2.1 and a total intrinsic value of $ 13 . All of the stock options outstanding were fully vested and exercisable. In 2024, 2023, and 2022, the cash received from stock option exercises was $ 8 , $ 11 , and $ 16 , respectively, and the total tax benefit realized from these exercises was $ 3 , $ 2 , and $ 2 , respectively. The total intrinsic value of stock options exercised during 2024, 2023, and 2022 was $ 16 , $ 9 , and $ 10 , respectively. The total intrinsic value of stock awards converted during 2024, 2023, and 2022 was $ 117 , $ 187 , and $ 61 , respectively. | text | 16 | monetaryItemType | text: <entity> 16 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the stock options outstanding had a weighted average remaining contractual life of 2.1 and a total intrinsic value of $ 13 . All of the stock options outstanding were fully vested and exercisable. In 2024, 2023, and 2022, the cash received from stock option exercises was $ 8 , $ 11 , and $ 16 , respectively, and the total tax benefit realized from these exercises was $ 3 , $ 2 , and $ 2 , respectively. The total intrinsic value of stock options exercised during 2024, 2023, and 2022 was $ 16 , $ 9 , and $ 10 , respectively. The total intrinsic value of stock awards converted during 2024, 2023, and 2022 was $ 117 , $ 187 , and $ 61 , respectively. </context> | us-gaap:ProceedsFromStockOptionsExercised |
As of December 31, 2024, the stock options outstanding had a weighted average remaining contractual life of 2.1 and a total intrinsic value of $ 13 . All of the stock options outstanding were fully vested and exercisable. In 2024, 2023, and 2022, the cash received from stock option exercises was $ 8 , $ 11 , and $ 16 , respectively, and the total tax benefit realized from these exercises was $ 3 , $ 2 , and $ 2 , respectively. The total intrinsic value of stock options exercised during 2024, 2023, and 2022 was $ 16 , $ 9 , and $ 10 , respectively. The total intrinsic value of stock awards converted during 2024, 2023, and 2022 was $ 117 , $ 187 , and $ 61 , respectively. | text | 3 | monetaryItemType | text: <entity> 3 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the stock options outstanding had a weighted average remaining contractual life of 2.1 and a total intrinsic value of $ 13 . All of the stock options outstanding were fully vested and exercisable. In 2024, 2023, and 2022, the cash received from stock option exercises was $ 8 , $ 11 , and $ 16 , respectively, and the total tax benefit realized from these exercises was $ 3 , $ 2 , and $ 2 , respectively. The total intrinsic value of stock options exercised during 2024, 2023, and 2022 was $ 16 , $ 9 , and $ 10 , respectively. The total intrinsic value of stock awards converted during 2024, 2023, and 2022 was $ 117 , $ 187 , and $ 61 , respectively. </context> | us-gaap:DeferredTaxExpenseFromStockOptionsExercised |
As of December 31, 2024, the stock options outstanding had a weighted average remaining contractual life of 2.1 and a total intrinsic value of $ 13 . All of the stock options outstanding were fully vested and exercisable. In 2024, 2023, and 2022, the cash received from stock option exercises was $ 8 , $ 11 , and $ 16 , respectively, and the total tax benefit realized from these exercises was $ 3 , $ 2 , and $ 2 , respectively. The total intrinsic value of stock options exercised during 2024, 2023, and 2022 was $ 16 , $ 9 , and $ 10 , respectively. The total intrinsic value of stock awards converted during 2024, 2023, and 2022 was $ 117 , $ 187 , and $ 61 , respectively. | text | 2 | monetaryItemType | text: <entity> 2 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the stock options outstanding had a weighted average remaining contractual life of 2.1 and a total intrinsic value of $ 13 . All of the stock options outstanding were fully vested and exercisable. In 2024, 2023, and 2022, the cash received from stock option exercises was $ 8 , $ 11 , and $ 16 , respectively, and the total tax benefit realized from these exercises was $ 3 , $ 2 , and $ 2 , respectively. The total intrinsic value of stock options exercised during 2024, 2023, and 2022 was $ 16 , $ 9 , and $ 10 , respectively. The total intrinsic value of stock awards converted during 2024, 2023, and 2022 was $ 117 , $ 187 , and $ 61 , respectively. </context> | us-gaap:DeferredTaxExpenseFromStockOptionsExercised |
As of December 31, 2024, the stock options outstanding had a weighted average remaining contractual life of 2.1 and a total intrinsic value of $ 13 . All of the stock options outstanding were fully vested and exercisable. In 2024, 2023, and 2022, the cash received from stock option exercises was $ 8 , $ 11 , and $ 16 , respectively, and the total tax benefit realized from these exercises was $ 3 , $ 2 , and $ 2 , respectively. The total intrinsic value of stock options exercised during 2024, 2023, and 2022 was $ 16 , $ 9 , and $ 10 , respectively. The total intrinsic value of stock awards converted during 2024, 2023, and 2022 was $ 117 , $ 187 , and $ 61 , respectively. | text | 16 | monetaryItemType | text: <entity> 16 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the stock options outstanding had a weighted average remaining contractual life of 2.1 and a total intrinsic value of $ 13 . All of the stock options outstanding were fully vested and exercisable. In 2024, 2023, and 2022, the cash received from stock option exercises was $ 8 , $ 11 , and $ 16 , respectively, and the total tax benefit realized from these exercises was $ 3 , $ 2 , and $ 2 , respectively. The total intrinsic value of stock options exercised during 2024, 2023, and 2022 was $ 16 , $ 9 , and $ 10 , respectively. The total intrinsic value of stock awards converted during 2024, 2023, and 2022 was $ 117 , $ 187 , and $ 61 , respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
As of December 31, 2024, the stock options outstanding had a weighted average remaining contractual life of 2.1 and a total intrinsic value of $ 13 . All of the stock options outstanding were fully vested and exercisable. In 2024, 2023, and 2022, the cash received from stock option exercises was $ 8 , $ 11 , and $ 16 , respectively, and the total tax benefit realized from these exercises was $ 3 , $ 2 , and $ 2 , respectively. The total intrinsic value of stock options exercised during 2024, 2023, and 2022 was $ 16 , $ 9 , and $ 10 , respectively. The total intrinsic value of stock awards converted during 2024, 2023, and 2022 was $ 117 , $ 187 , and $ 61 , respectively. | text | 9 | monetaryItemType | text: <entity> 9 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the stock options outstanding had a weighted average remaining contractual life of 2.1 and a total intrinsic value of $ 13 . All of the stock options outstanding were fully vested and exercisable. In 2024, 2023, and 2022, the cash received from stock option exercises was $ 8 , $ 11 , and $ 16 , respectively, and the total tax benefit realized from these exercises was $ 3 , $ 2 , and $ 2 , respectively. The total intrinsic value of stock options exercised during 2024, 2023, and 2022 was $ 16 , $ 9 , and $ 10 , respectively. The total intrinsic value of stock awards converted during 2024, 2023, and 2022 was $ 117 , $ 187 , and $ 61 , respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
As of December 31, 2024, the stock options outstanding had a weighted average remaining contractual life of 2.1 and a total intrinsic value of $ 13 . All of the stock options outstanding were fully vested and exercisable. In 2024, 2023, and 2022, the cash received from stock option exercises was $ 8 , $ 11 , and $ 16 , respectively, and the total tax benefit realized from these exercises was $ 3 , $ 2 , and $ 2 , respectively. The total intrinsic value of stock options exercised during 2024, 2023, and 2022 was $ 16 , $ 9 , and $ 10 , respectively. The total intrinsic value of stock awards converted during 2024, 2023, and 2022 was $ 117 , $ 187 , and $ 61 , respectively. | text | 10 | monetaryItemType | text: <entity> 10 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the stock options outstanding had a weighted average remaining contractual life of 2.1 and a total intrinsic value of $ 13 . All of the stock options outstanding were fully vested and exercisable. In 2024, 2023, and 2022, the cash received from stock option exercises was $ 8 , $ 11 , and $ 16 , respectively, and the total tax benefit realized from these exercises was $ 3 , $ 2 , and $ 2 , respectively. The total intrinsic value of stock options exercised during 2024, 2023, and 2022 was $ 16 , $ 9 , and $ 10 , respectively. The total intrinsic value of stock awards converted during 2024, 2023, and 2022 was $ 117 , $ 187 , and $ 61 , respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
Common stock outstanding as of December 31, 2024, 2023, and 2022 was approximately 405 million, 410 million, and 412 million, respectively. | text | 405 | sharesItemType | text: <entity> 405 </entity> <entity type> sharesItemType </entity type> <context> Common stock outstanding as of December 31, 2024, 2023, and 2022 was approximately 405 million, 410 million, and 412 million, respectively. </context> | us-gaap:CommonStockSharesOutstanding |
Common stock outstanding as of December 31, 2024, 2023, and 2022 was approximately 405 million, 410 million, and 412 million, respectively. | text | 410 | sharesItemType | text: <entity> 410 </entity> <entity type> sharesItemType </entity type> <context> Common stock outstanding as of December 31, 2024, 2023, and 2022 was approximately 405 million, 410 million, and 412 million, respectively. </context> | us-gaap:CommonStockSharesOutstanding |
Common stock outstanding as of December 31, 2024, 2023, and 2022 was approximately 405 million, 410 million, and 412 million, respectively. | text | 412 | sharesItemType | text: <entity> 412 </entity> <entity type> sharesItemType </entity type> <context> Common stock outstanding as of December 31, 2024, 2023, and 2022 was approximately 405 million, 410 million, and 412 million, respectively. </context> | us-gaap:CommonStockSharesOutstanding |
The Company sold $ 1,625 and $ 1,547 of its receivables without recourse and received cash funding under this program during 2024 and 2023, respectively, resulting in derecognition of the receivables from the Company’s Consolidated Balance Sheet. Costs associated with the sales of receivables are reflected in the Company’s Statement of Consolidated Operations in Other expense, net for the periods in which the sales occur. Cash receipts from sold receivables under the Receivables Purchase Agreement are presented within operating activities in the Statement of Consolidated Cash Flows. | text | 1625 | monetaryItemType | text: <entity> 1625 </entity> <entity type> monetaryItemType </entity type> <context> The Company sold $ 1,625 and $ 1,547 of its receivables without recourse and received cash funding under this program during 2024 and 2023, respectively, resulting in derecognition of the receivables from the Company’s Consolidated Balance Sheet. Costs associated with the sales of receivables are reflected in the Company’s Statement of Consolidated Operations in Other expense, net for the periods in which the sales occur. Cash receipts from sold receivables under the Receivables Purchase Agreement are presented within operating activities in the Statement of Consolidated Cash Flows. </context> | us-gaap:AccountsReceivableSale |
The Company sold $ 1,625 and $ 1,547 of its receivables without recourse and received cash funding under this program during 2024 and 2023, respectively, resulting in derecognition of the receivables from the Company’s Consolidated Balance Sheet. Costs associated with the sales of receivables are reflected in the Company’s Statement of Consolidated Operations in Other expense, net for the periods in which the sales occur. Cash receipts from sold receivables under the Receivables Purchase Agreement are presented within operating activities in the Statement of Consolidated Cash Flows. | text | 1547 | monetaryItemType | text: <entity> 1547 </entity> <entity type> monetaryItemType </entity type> <context> The Company sold $ 1,625 and $ 1,547 of its receivables without recourse and received cash funding under this program during 2024 and 2023, respectively, resulting in derecognition of the receivables from the Company’s Consolidated Balance Sheet. Costs associated with the sales of receivables are reflected in the Company’s Statement of Consolidated Operations in Other expense, net for the periods in which the sales occur. Cash receipts from sold receivables under the Receivables Purchase Agreement are presented within operating activities in the Statement of Consolidated Cash Flows. </context> | us-gaap:AccountsReceivableSale |
In 2024 and 2023, the Company sold $ 712 and $ 593 , respectively, of certain customers’ receivables in exchange for cash (of which $ 190 and $ 158 was outstanding from customers as of December 31, 2024 and December 31, 2023, respectively), the proceeds from which are presented in changes in receivables within operating activities in the Statement of Consolidated Cash Flows. Costs associated with the sales of receivables are reflected in the Company’s Statement of Consolidated Operations in Other expense, net for the periods in which the sales occur. | text | 712 | monetaryItemType | text: <entity> 712 </entity> <entity type> monetaryItemType </entity type> <context> In 2024 and 2023, the Company sold $ 712 and $ 593 , respectively, of certain customers’ receivables in exchange for cash (of which $ 190 and $ 158 was outstanding from customers as of December 31, 2024 and December 31, 2023, respectively), the proceeds from which are presented in changes in receivables within operating activities in the Statement of Consolidated Cash Flows. Costs associated with the sales of receivables are reflected in the Company’s Statement of Consolidated Operations in Other expense, net for the periods in which the sales occur. </context> | us-gaap:AccountsReceivableSale |
In 2024 and 2023, the Company sold $ 712 and $ 593 , respectively, of certain customers’ receivables in exchange for cash (of which $ 190 and $ 158 was outstanding from customers as of December 31, 2024 and December 31, 2023, respectively), the proceeds from which are presented in changes in receivables within operating activities in the Statement of Consolidated Cash Flows. Costs associated with the sales of receivables are reflected in the Company’s Statement of Consolidated Operations in Other expense, net for the periods in which the sales occur. | text | 593 | monetaryItemType | text: <entity> 593 </entity> <entity type> monetaryItemType </entity type> <context> In 2024 and 2023, the Company sold $ 712 and $ 593 , respectively, of certain customers’ receivables in exchange for cash (of which $ 190 and $ 158 was outstanding from customers as of December 31, 2024 and December 31, 2023, respectively), the proceeds from which are presented in changes in receivables within operating activities in the Statement of Consolidated Cash Flows. Costs associated with the sales of receivables are reflected in the Company’s Statement of Consolidated Operations in Other expense, net for the periods in which the sales occur. </context> | us-gaap:AccountsReceivableSale |
Depreciation expense related to Properties, plants, and equipment recorded in Provision for depreciation and amortization in the Statement of Consolidated Operations was $ 243 , $ 236 , and $ 227 for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 243 | monetaryItemType | text: <entity> 243 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense related to Properties, plants, and equipment recorded in Provision for depreciation and amortization in the Statement of Consolidated Operations was $ 243 , $ 236 , and $ 227 for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:Depreciation |
Depreciation expense related to Properties, plants, and equipment recorded in Provision for depreciation and amortization in the Statement of Consolidated Operations was $ 243 , $ 236 , and $ 227 for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 236 | monetaryItemType | text: <entity> 236 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense related to Properties, plants, and equipment recorded in Provision for depreciation and amortization in the Statement of Consolidated Operations was $ 243 , $ 236 , and $ 227 for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:Depreciation |
Depreciation expense related to Properties, plants, and equipment recorded in Provision for depreciation and amortization in the Statement of Consolidated Operations was $ 243 , $ 236 , and $ 227 for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 227 | monetaryItemType | text: <entity> 227 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense related to Properties, plants, and equipment recorded in Provision for depreciation and amortization in the Statement of Consolidated Operations was $ 243 , $ 236 , and $ 227 for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:Depreciation |
During the 2024 annual review of goodwill in the fourth quarter, management performed quantitative assessments on the Engine Products and Engineered Structures reporting units and qualitative assessments on the Fastening Systems and Forged Wheels reporting units. The estimated fair values of the reporting units exceeded their respective carrying values in excess of 60 %; thus, there were no goodwill impairments. Howmet uses a DCF model to estimate the current fair value of the reporting unit, which is compared to its carrying value, when testing for impairment. Management believes forecasted cash flows are the best indicator of such fair value. A number of significant assumptions and estimates are involved in the application of the DCF model to forecast operating cash flows, including sales growth, production costs, and discount rate. Assumptions can vary among the reporting units. Cash flow forecasts are generally based on approved business unit operating plans for the early years and historical relationships in later years. The WACC rate for the individual reporting units is estimated with the assistance of valuation experts. The annual goodwill impairment tests in the fourth quarters of 2024, 2023, and 2022 indicated that goodwill was not impaired for any of the Company’s reporting units. If actual results or external market factors decline significantly from management’s estimates, future goodwill impairment charges (or the amount by which the carrying amount exceeds the reporting unit’s fair value without exceeding the total amount of goodwill allocated to that reporting unit) may be necessary and could be material. | text | 60 | percentItemType | text: <entity> 60 </entity> <entity type> percentItemType </entity type> <context> During the 2024 annual review of goodwill in the fourth quarter, management performed quantitative assessments on the Engine Products and Engineered Structures reporting units and qualitative assessments on the Fastening Systems and Forged Wheels reporting units. The estimated fair values of the reporting units exceeded their respective carrying values in excess of 60 %; thus, there were no goodwill impairments. Howmet uses a DCF model to estimate the current fair value of the reporting unit, which is compared to its carrying value, when testing for impairment. Management believes forecasted cash flows are the best indicator of such fair value. A number of significant assumptions and estimates are involved in the application of the DCF model to forecast operating cash flows, including sales growth, production costs, and discount rate. Assumptions can vary among the reporting units. Cash flow forecasts are generally based on approved business unit operating plans for the early years and historical relationships in later years. The WACC rate for the individual reporting units is estimated with the assistance of valuation experts. The annual goodwill impairment tests in the fourth quarters of 2024, 2023, and 2022 indicated that goodwill was not impaired for any of the Company’s reporting units. If actual results or external market factors decline significantly from management’s estimates, future goodwill impairment charges (or the amount by which the carrying amount exceeds the reporting unit’s fair value without exceeding the total amount of goodwill allocated to that reporting unit) may be necessary and could be material. </context> | us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount |
During the 2024 annual review of goodwill in the fourth quarter, management performed quantitative assessments on the Engine Products and Engineered Structures reporting units and qualitative assessments on the Fastening Systems and Forged Wheels reporting units. The estimated fair values of the reporting units exceeded their respective carrying values in excess of 60 %; thus, there were no goodwill impairments. Howmet uses a DCF model to estimate the current fair value of the reporting unit, which is compared to its carrying value, when testing for impairment. Management believes forecasted cash flows are the best indicator of such fair value. A number of significant assumptions and estimates are involved in the application of the DCF model to forecast operating cash flows, including sales growth, production costs, and discount rate. Assumptions can vary among the reporting units. Cash flow forecasts are generally based on approved business unit operating plans for the early years and historical relationships in later years. The WACC rate for the individual reporting units is estimated with the assistance of valuation experts. The annual goodwill impairment tests in the fourth quarters of 2024, 2023, and 2022 indicated that goodwill was not impaired for any of the Company’s reporting units. If actual results or external market factors decline significantly from management’s estimates, future goodwill impairment charges (or the amount by which the carrying amount exceeds the reporting unit’s fair value without exceeding the total amount of goodwill allocated to that reporting unit) may be necessary and could be material. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> During the 2024 annual review of goodwill in the fourth quarter, management performed quantitative assessments on the Engine Products and Engineered Structures reporting units and qualitative assessments on the Fastening Systems and Forged Wheels reporting units. The estimated fair values of the reporting units exceeded their respective carrying values in excess of 60 %; thus, there were no goodwill impairments. Howmet uses a DCF model to estimate the current fair value of the reporting unit, which is compared to its carrying value, when testing for impairment. Management believes forecasted cash flows are the best indicator of such fair value. A number of significant assumptions and estimates are involved in the application of the DCF model to forecast operating cash flows, including sales growth, production costs, and discount rate. Assumptions can vary among the reporting units. Cash flow forecasts are generally based on approved business unit operating plans for the early years and historical relationships in later years. The WACC rate for the individual reporting units is estimated with the assistance of valuation experts. The annual goodwill impairment tests in the fourth quarters of 2024, 2023, and 2022 indicated that goodwill was not impaired for any of the Company’s reporting units. If actual results or external market factors decline significantly from management’s estimates, future goodwill impairment charges (or the amount by which the carrying amount exceeds the reporting unit’s fair value without exceeding the total amount of goodwill allocated to that reporting unit) may be necessary and could be material. </context> | us-gaap:GoodwillImpairmentLoss |
Amortization expense related to the intangible assets recorded in Provision for depreciation and amortization in the Statement of Consolidated Operations was $ 33 , $ 35 , and $ 36 for the years ended December 31, 2024, 2023, and 2022, respectively, and is expected to be in the range of approximately $ 30 to $ 36 annually from 2025 to 2029. | text | 33 | monetaryItemType | text: <entity> 33 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense related to the intangible assets recorded in Provision for depreciation and amortization in the Statement of Consolidated Operations was $ 33 , $ 35 , and $ 36 for the years ended December 31, 2024, 2023, and 2022, respectively, and is expected to be in the range of approximately $ 30 to $ 36 annually from 2025 to 2029. </context> | us-gaap:AmortizationOfIntangibleAssets |
Amortization expense related to the intangible assets recorded in Provision for depreciation and amortization in the Statement of Consolidated Operations was $ 33 , $ 35 , and $ 36 for the years ended December 31, 2024, 2023, and 2022, respectively, and is expected to be in the range of approximately $ 30 to $ 36 annually from 2025 to 2029. | text | 35 | monetaryItemType | text: <entity> 35 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense related to the intangible assets recorded in Provision for depreciation and amortization in the Statement of Consolidated Operations was $ 33 , $ 35 , and $ 36 for the years ended December 31, 2024, 2023, and 2022, respectively, and is expected to be in the range of approximately $ 30 to $ 36 annually from 2025 to 2029. </context> | us-gaap:AmortizationOfIntangibleAssets |
Amortization expense related to the intangible assets recorded in Provision for depreciation and amortization in the Statement of Consolidated Operations was $ 33 , $ 35 , and $ 36 for the years ended December 31, 2024, 2023, and 2022, respectively, and is expected to be in the range of approximately $ 30 to $ 36 annually from 2025 to 2029. | text | 36 | monetaryItemType | text: <entity> 36 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense related to the intangible assets recorded in Provision for depreciation and amortization in the Statement of Consolidated Operations was $ 33 , $ 35 , and $ 36 for the years ended December 31, 2024, 2023, and 2022, respectively, and is expected to be in the range of approximately $ 30 to $ 36 annually from 2025 to 2029. </context> | us-gaap:AmortizationOfIntangibleAssets |
Operating lease cost includes short-term leases and variable lease payments and approximates cash paid. Operating lease cost was $ 67 , $ 63 , and $ 61 in 2024, 2023, and 2022, respectively. Operating lease cost in 2024, 2023, and the second half of 2022 includes the lease for the portion of the property in Pittsburgh, PA used as the corporate headquarters. | text | 67 | monetaryItemType | text: <entity> 67 </entity> <entity type> monetaryItemType </entity type> <context> Operating lease cost includes short-term leases and variable lease payments and approximates cash paid. Operating lease cost was $ 67 , $ 63 , and $ 61 in 2024, 2023, and 2022, respectively. Operating lease cost in 2024, 2023, and the second half of 2022 includes the lease for the portion of the property in Pittsburgh, PA used as the corporate headquarters. </context> | us-gaap:OperatingLeaseCost |
Operating lease cost includes short-term leases and variable lease payments and approximates cash paid. Operating lease cost was $ 67 , $ 63 , and $ 61 in 2024, 2023, and 2022, respectively. Operating lease cost in 2024, 2023, and the second half of 2022 includes the lease for the portion of the property in Pittsburgh, PA used as the corporate headquarters. | text | 63 | monetaryItemType | text: <entity> 63 </entity> <entity type> monetaryItemType </entity type> <context> Operating lease cost includes short-term leases and variable lease payments and approximates cash paid. Operating lease cost was $ 67 , $ 63 , and $ 61 in 2024, 2023, and 2022, respectively. Operating lease cost in 2024, 2023, and the second half of 2022 includes the lease for the portion of the property in Pittsburgh, PA used as the corporate headquarters. </context> | us-gaap:OperatingLeaseCost |
Operating lease cost includes short-term leases and variable lease payments and approximates cash paid. Operating lease cost was $ 67 , $ 63 , and $ 61 in 2024, 2023, and 2022, respectively. Operating lease cost in 2024, 2023, and the second half of 2022 includes the lease for the portion of the property in Pittsburgh, PA used as the corporate headquarters. | text | 61 | monetaryItemType | text: <entity> 61 </entity> <entity type> monetaryItemType </entity type> <context> Operating lease cost includes short-term leases and variable lease payments and approximates cash paid. Operating lease cost was $ 67 , $ 63 , and $ 61 in 2024, 2023, and 2022, respectively. Operating lease cost in 2024, 2023, and the second half of 2022 includes the lease for the portion of the property in Pittsburgh, PA used as the corporate headquarters. </context> | us-gaap:OperatingLeaseCost |
The Company entered into a cross-currency swap to synthetically convert the 2031 Notes into a Euro liability of approximately € 458 million with a fixed annual interest rate of 3.720 %. | text | 458 | monetaryItemType | text: <entity> 458 </entity> <entity type> monetaryItemType </entity type> <context> The Company entered into a cross-currency swap to synthetically convert the 2031 Notes into a Euro liability of approximately € 458 million with a fixed annual interest rate of 3.720 %. </context> | us-gaap:DerivativeLiabilities |
The Company entered into a cross-currency swap to synthetically convert the 2031 Notes into a Euro liability of approximately € 458 million with a fixed annual interest rate of 3.720 %. | text | 3.720 | percentItemType | text: <entity> 3.720 </entity> <entity type> percentItemType </entity type> <context> The Company entered into a cross-currency swap to synthetically convert the 2031 Notes into a Euro liability of approximately € 458 million with a fixed annual interest rate of 3.720 %. </context> | us-gaap:DerivativeFixedInterestRate |
The principal amount of long-term debt maturing in each of the next five years is $ 5 in 2025, $ 323 in 2026, $ 625 in 2027, $ 300 in 2028, and $ 700 in 2029. | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> The principal amount of long-term debt maturing in each of the next five years is $ 5 in 2025, $ 323 in 2026, $ 625 in 2027, $ 300 in 2028, and $ 700 in 2029. </context> | us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths |
The principal amount of long-term debt maturing in each of the next five years is $ 5 in 2025, $ 323 in 2026, $ 625 in 2027, $ 300 in 2028, and $ 700 in 2029. | text | 323 | monetaryItemType | text: <entity> 323 </entity> <entity type> monetaryItemType </entity type> <context> The principal amount of long-term debt maturing in each of the next five years is $ 5 in 2025, $ 323 in 2026, $ 625 in 2027, $ 300 in 2028, and $ 700 in 2029. </context> | us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo |
The principal amount of long-term debt maturing in each of the next five years is $ 5 in 2025, $ 323 in 2026, $ 625 in 2027, $ 300 in 2028, and $ 700 in 2029. | text | 625 | monetaryItemType | text: <entity> 625 </entity> <entity type> monetaryItemType </entity type> <context> The principal amount of long-term debt maturing in each of the next five years is $ 5 in 2025, $ 323 in 2026, $ 625 in 2027, $ 300 in 2028, and $ 700 in 2029. </context> | us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree |
The principal amount of long-term debt maturing in each of the next five years is $ 5 in 2025, $ 323 in 2026, $ 625 in 2027, $ 300 in 2028, and $ 700 in 2029. | text | 300 | monetaryItemType | text: <entity> 300 </entity> <entity type> monetaryItemType </entity type> <context> The principal amount of long-term debt maturing in each of the next five years is $ 5 in 2025, $ 323 in 2026, $ 625 in 2027, $ 300 in 2028, and $ 700 in 2029. </context> | us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour |
The principal amount of long-term debt maturing in each of the next five years is $ 5 in 2025, $ 323 in 2026, $ 625 in 2027, $ 300 in 2028, and $ 700 in 2029. | text | 700 | monetaryItemType | text: <entity> 700 </entity> <entity type> monetaryItemType </entity type> <context> The principal amount of long-term debt maturing in each of the next five years is $ 5 in 2025, $ 323 in 2026, $ 625 in 2027, $ 300 in 2028, and $ 700 in 2029. </context> | us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive |
On August 23, 2024, the Company completed the early redemption of all of the remaining outstanding principal amount of approximately $ 577 of the 6.875 % Notes due May 2025 (the “2025 Notes”) in accordance with the terms of the notes. The Company completed the redemption with the net proceeds from the offering of the 4.850 % Notes due October 2031 (the “2031 Notes”) and cash on hand at an aggregate redemption price of approximately $ 594 , including accrued interest and an early termination premium of approximately $ 12 and $ 5 , respectively, which were recorded in Interest expense, net, and Loss on debt redemption, respectively, in the Statement of Consolidated Operations. | text | 577 | monetaryItemType | text: <entity> 577 </entity> <entity type> monetaryItemType </entity type> <context> On August 23, 2024, the Company completed the early redemption of all of the remaining outstanding principal amount of approximately $ 577 of the 6.875 % Notes due May 2025 (the “2025 Notes”) in accordance with the terms of the notes. The Company completed the redemption with the net proceeds from the offering of the 4.850 % Notes due October 2031 (the “2031 Notes”) and cash on hand at an aggregate redemption price of approximately $ 594 , including accrued interest and an early termination premium of approximately $ 12 and $ 5 , respectively, which were recorded in Interest expense, net, and Loss on debt redemption, respectively, in the Statement of Consolidated Operations. </context> | us-gaap:DebtInstrumentCarryingAmount |
On August 23, 2024, the Company completed the early redemption of all of the remaining outstanding principal amount of approximately $ 577 of the 6.875 % Notes due May 2025 (the “2025 Notes”) in accordance with the terms of the notes. The Company completed the redemption with the net proceeds from the offering of the 4.850 % Notes due October 2031 (the “2031 Notes”) and cash on hand at an aggregate redemption price of approximately $ 594 , including accrued interest and an early termination premium of approximately $ 12 and $ 5 , respectively, which were recorded in Interest expense, net, and Loss on debt redemption, respectively, in the Statement of Consolidated Operations. | text | 6.875 | percentItemType | text: <entity> 6.875 </entity> <entity type> percentItemType </entity type> <context> On August 23, 2024, the Company completed the early redemption of all of the remaining outstanding principal amount of approximately $ 577 of the 6.875 % Notes due May 2025 (the “2025 Notes”) in accordance with the terms of the notes. The Company completed the redemption with the net proceeds from the offering of the 4.850 % Notes due October 2031 (the “2031 Notes”) and cash on hand at an aggregate redemption price of approximately $ 594 , including accrued interest and an early termination premium of approximately $ 12 and $ 5 , respectively, which were recorded in Interest expense, net, and Loss on debt redemption, respectively, in the Statement of Consolidated Operations. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
On August 23, 2024, the Company completed the early redemption of all of the remaining outstanding principal amount of approximately $ 577 of the 6.875 % Notes due May 2025 (the “2025 Notes”) in accordance with the terms of the notes. The Company completed the redemption with the net proceeds from the offering of the 4.850 % Notes due October 2031 (the “2031 Notes”) and cash on hand at an aggregate redemption price of approximately $ 594 , including accrued interest and an early termination premium of approximately $ 12 and $ 5 , respectively, which were recorded in Interest expense, net, and Loss on debt redemption, respectively, in the Statement of Consolidated Operations. | text | 4.850 | percentItemType | text: <entity> 4.850 </entity> <entity type> percentItemType </entity type> <context> On August 23, 2024, the Company completed the early redemption of all of the remaining outstanding principal amount of approximately $ 577 of the 6.875 % Notes due May 2025 (the “2025 Notes”) in accordance with the terms of the notes. The Company completed the redemption with the net proceeds from the offering of the 4.850 % Notes due October 2031 (the “2031 Notes”) and cash on hand at an aggregate redemption price of approximately $ 594 , including accrued interest and an early termination premium of approximately $ 12 and $ 5 , respectively, which were recorded in Interest expense, net, and Loss on debt redemption, respectively, in the Statement of Consolidated Operations. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
On August 23, 2024, the Company completed the early redemption of all of the remaining outstanding principal amount of approximately $ 577 of the 6.875 % Notes due May 2025 (the “2025 Notes”) in accordance with the terms of the notes. The Company completed the redemption with the net proceeds from the offering of the 4.850 % Notes due October 2031 (the “2031 Notes”) and cash on hand at an aggregate redemption price of approximately $ 594 , including accrued interest and an early termination premium of approximately $ 12 and $ 5 , respectively, which were recorded in Interest expense, net, and Loss on debt redemption, respectively, in the Statement of Consolidated Operations. | text | 12 | monetaryItemType | text: <entity> 12 </entity> <entity type> monetaryItemType </entity type> <context> On August 23, 2024, the Company completed the early redemption of all of the remaining outstanding principal amount of approximately $ 577 of the 6.875 % Notes due May 2025 (the “2025 Notes”) in accordance with the terms of the notes. The Company completed the redemption with the net proceeds from the offering of the 4.850 % Notes due October 2031 (the “2031 Notes”) and cash on hand at an aggregate redemption price of approximately $ 594 , including accrued interest and an early termination premium of approximately $ 12 and $ 5 , respectively, which were recorded in Interest expense, net, and Loss on debt redemption, respectively, in the Statement of Consolidated Operations. </context> | us-gaap:InterestExpenseDebt |
On August 22, 2024, the Company completed an offering of $ 500 aggregate principal amount of its 2031 Notes. The Company entered into a cross-currency swap to synthetically convert the 2031 Notes into a Euro liability of approximately € 458 million. The fixed interest rate on the Euro liability is approximately 3.720 % per annum. | text | 500 | monetaryItemType | text: <entity> 500 </entity> <entity type> monetaryItemType </entity type> <context> On August 22, 2024, the Company completed an offering of $ 500 aggregate principal amount of its 2031 Notes. The Company entered into a cross-currency swap to synthetically convert the 2031 Notes into a Euro liability of approximately € 458 million. The fixed interest rate on the Euro liability is approximately 3.720 % per annum. </context> | us-gaap:DebtInstrumentFaceAmount |
On August 22, 2024, the Company completed an offering of $ 500 aggregate principal amount of its 2031 Notes. The Company entered into a cross-currency swap to synthetically convert the 2031 Notes into a Euro liability of approximately € 458 million. The fixed interest rate on the Euro liability is approximately 3.720 % per annum. | text | 458 | monetaryItemType | text: <entity> 458 </entity> <entity type> monetaryItemType </entity type> <context> On August 22, 2024, the Company completed an offering of $ 500 aggregate principal amount of its 2031 Notes. The Company entered into a cross-currency swap to synthetically convert the 2031 Notes into a Euro liability of approximately € 458 million. The fixed interest rate on the Euro liability is approximately 3.720 % per annum. </context> | us-gaap:DerivativeLiabilities |
On August 22, 2024, the Company completed an offering of $ 500 aggregate principal amount of its 2031 Notes. The Company entered into a cross-currency swap to synthetically convert the 2031 Notes into a Euro liability of approximately € 458 million. The fixed interest rate on the Euro liability is approximately 3.720 % per annum. | text | 3.720 | percentItemType | text: <entity> 3.720 </entity> <entity type> percentItemType </entity type> <context> On August 22, 2024, the Company completed an offering of $ 500 aggregate principal amount of its 2031 Notes. The Company entered into a cross-currency swap to synthetically convert the 2031 Notes into a Euro liability of approximately € 458 million. The fixed interest rate on the Euro liability is approximately 3.720 % per annum. </context> | us-gaap:DerivativeFixedInterestRate |
On July 1, 2024, the Company completed the early redemption of all of the remaining outstanding principal amount of $ 205 of the 5.125 % Notes due October 2024 (the “ | text | 205 | monetaryItemType | text: <entity> 205 </entity> <entity type> monetaryItemType </entity type> <context> On July 1, 2024, the Company completed the early redemption of all of the remaining outstanding principal amount of $ 205 of the 5.125 % Notes due October 2024 (the “ </context> | us-gaap:ExtinguishmentOfDebtAmount |
On July 1, 2024, the Company completed the early redemption of all of the remaining outstanding principal amount of $ 205 of the 5.125 % Notes due October 2024 (the “ | text | 5.125 | percentItemType | text: <entity> 5.125 </entity> <entity type> percentItemType </entity type> <context> On July 1, 2024, the Company completed the early redemption of all of the remaining outstanding principal amount of $ 205 of the 5.125 % Notes due October 2024 (the “ </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
were redeemed with cash on hand at an aggregate redemption price of approximately $ 208 , including accrued interest of approximately $ 3 . | text | 3 | monetaryItemType | text: <entity> 3 </entity> <entity type> monetaryItemType </entity type> <context> were redeemed with cash on hand at an aggregate redemption price of approximately $ 208 , including accrued interest of approximately $ 3 . </context> | us-gaap:InterestPayableCurrentAndNoncurrent |
In the second quarter of 2024, the Company repurchased approximately $ 23 aggregate principal amount of the 2025 Notes through an open market repurchase (“OMR”). The OMR was settled at slightly more than par value. | text | 23 | monetaryItemType | text: <entity> 23 </entity> <entity type> monetaryItemType </entity type> <context> In the second quarter of 2024, the Company repurchased approximately $ 23 aggregate principal amount of the 2025 Notes through an open market repurchase (“OMR”). The OMR was settled at slightly more than par value. </context> | us-gaap:DebtInstrumentRepurchasedFaceAmount |
in the aggregate principal amount of $ 500 . Such | text | 500 | monetaryItemType | text: <entity> 500 </entity> <entity type> monetaryItemType </entity type> <context> in the aggregate principal amount of $ 500 . Such </context> | us-gaap:ExtinguishmentOfDebtAmount |
were redeemed at par with approximately $ 106 of cash on hand and approximately $ 400 from the Company’s term loan facilities at an aggregate redemption price of approximately $ 506 , including accrued interest of approximately $ 6 . | text | 6 | monetaryItemType | text: <entity> 6 </entity> <entity type> monetaryItemType </entity type> <context> were redeemed at par with approximately $ 106 of cash on hand and approximately $ 400 from the Company’s term loan facilities at an aggregate redemption price of approximately $ 506 , including accrued interest of approximately $ 6 . </context> | us-gaap:InterestPayableCurrentAndNoncurrent |
in the aggregate principal amount of $ 200 . Such | text | 200 | monetaryItemType | text: <entity> 200 </entity> <entity type> monetaryItemType </entity type> <context> in the aggregate principal amount of $ 200 . Such </context> | us-gaap:ExtinguishmentOfDebtAmount |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.